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84. ABSTRACT
Introduction: There is an ongoing controversy as to whether there has been a significant
reduction in amputations and by what means amputations are avoided in patients with
critical leg ischaemia. 
Aims of the present study: The aim of this study was to evaluate the incidence of major
amputation and the outcome of amputees in two well defined areas and the association
between revascularisation and amputation. 
Methods:
1. The outcome of 169 major lower limb amputations during the period 1997-2000 in the
Seinäjoki Central Hospital region (area I) was investigated retrospectively. The annual
incidence of major amputation was assessed.
2. The outcome of 215 major lower limb amputations in 2000 in Southern Finland (area II)
was reviewed retrospectively. The annual incidence of major amputation and infrainguinal
(or infrapopliteal) bypass during the period 1990-2001 was assessed. 
3. A nation-wide study was undertaken to analyse retrospectively data on infrapopliteal
bypasses and major amputations for patients aged ≥ 70 years with critical leg ischaemia.
Hospital regions were divided into two equal groups according to the numbers of
infrapopliteal bypasses performed on patients aged ≥ 80 years.
4. The outcome of 230 critically ischaemic limbs treated with infrainguinal percutaneous
transluminal angioplasty at Helsinki University Central Hospital during the period 2000-
2002 were analyzed retrospectively. 
5. The clinical records of 1094 patients who underwent major lower limb amputation for
vascular disease in Helsinki during the period 1990-2002 were analyzed retrospectively.
The study period was divided into three parts (1990-1994, 1995-1998 and 1999-2002) and
results were compared between diabetic and nondiabetic vascular amputees for each part.
9Results: 
1.The incidence of major lower limb amputation (lost legs) in 2000 was 152 (I) and 135 (II)
per million inhabitants respectively in the two areas studied. 
2. In study area II, the decrease in amputation incidence over the period 1990-2000 was
25% and the decrease in age-adjusted amputation incidence 30%. Over this period there
was a significant inverse correlation between incidence of infrainguinal bypass and
amputation (r=-0.682, p=0.021) and between incidence of infrapopliteal bypass and
amputation (r=-0.682, p=0.021).
3. The incidences of major amputation in the active group (978 bypasses per million
inhabitants) and passive group (57 per million) were 1976 and 3177 per million
respectively (p=0.016). There was a significant (p=0.012) inverse relationship between the
numbers of infrapopliteal bypass operations and major amputations in patients aged ≥ 80
years.
4. In the series of patients with critical leg ischaemia treated with percutaneous
transluminal angioplasty, primary patency, secondary patency, limb salvage and survival
rates were 47%, 59%, 92% and 76% respectively at 12 months. 
5. The overall incidence of major amputations in diabetics and nondiabetics decreased by
23% and 40% respectively from the first period (1990-1994) to the last (1999-2002). 
Conclusions: 
1. Active revascularisation saves legs from major amputation.
2. Infrapopliteal bypass can be considered as an index-procedure in preventing major
amputations.
3. A decrease in amputation rates among elderly patients can be achieved at least as well
as in younger patients by means of active revascularisation. 
4. Percutaneous transluminal angioplasty can be considered as a first-line treatment in a
selected group of patients with critical leg ischaemia, as it gives good limb salvage rates. 
5. The decrease in major amputation rates among diabetic as well as nondiabetic patients
can be attributed to the increased interest in amputation prevention.
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5. INTRODUCTION
The definition of a lower extremity amputation is the complete loss of any part of the lower
limb for any reason. A major amputation is defined as an amputation proximal to the
tarsometatarsal joint and a minor amputation as one (through or) distal to this joint (Group
TG 2000). In practice, the most important landmark is the heel, and therefore major
amputations are those above heel level. As very few amputations are of Lisfranc, Chopart
or Syme type (Solonen 1991), these two approaches distinguish almost the same groups
of patients. For the patient, there is a vast difference between minor and major
amputations: minor amputations do not restrict function and mobility as major amputations
do. Thus, these two amputation types should be reported separately. 
The majority of major lower limb amputations are currently performed for critical leg
ischaemia (CLI) (Alaranta et al. 1995; Ebskov 1992; Group TG 2000; Laaperi et al. 1993;
Pohjolainen and Alaranta 1988; Pohjolainen and Alaranta 1999). Treatment of CLI is one
of the most important tasks of vascular surgery, and it accounts for a major part (35%) of
vascular surgical activity in Finland (Luther et al. 2000). One of the main goals in vascular
surgery is to obviate the need for major amputation. From the vascular surgeon´s point of
view, only major amputations count as possible treatment failures, and only if the leg was
salvageable by some means of revascularisation (Lepantalo et al. 2000). Nonambulatory
patients, who require a stable, pain-free limb, and institutionalised patients and those with
terminal co-morbid conditions will gain no benefit from revascularisation procedures
(Biancari et al. 2000; Humphreys et al. 1995; Johnson et al. 1995). Whatever the decision,
all potentially ambulant patients with CLI should be seen by a vascular surgeon before
amputation is recommended (Lepantalo et al. 2000; Shearman et al. 2000; Wahlberg et al.
1994).
Treatment stategies for CLI still vary greatly, in Finland and elsewhere (Bradbury et al.
2002; Luther et al. 2000). The same patients may receive entirely different treatment
depending on which hospital they attend (Bradbury et al. 2002). The role of percutaneous
transluminal angioplasty (PTA) in treating CLI patients has become an issue of increasing
interest, but also a source of controversy (Bradbury et al. 2002; Bradbury and Ruckley
11
1996). To ascertain the appropriate treatment methods for CLI, more data on different
treatment strategies is needed. The aim of this study was to seek this information.
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6. REVIEW OF THE LITERATURE
6.1 Etiology of lower limb major amputations
Vascular causes account for the majority of major lower limb amputations performed in the
Western world during peacetime (Alaranta et al. 1995; Ebskov 1992; Group TG 2000;
Laaperi et al. 1993; Pohjolainen and Alaranta 1988; Pohjolainen and Alaranta 1999).
Lower-limb amputations performed for other reasons, such as trauma or tumour, have
decreased in significance. The main causes of lower limb amputations and the proportion
of different diagnoses are listed in Table 1 (Alaranta et al. 1995; Ebskov 1992; Group TG
2000; Laaperi et al. 1993; Pohjolainen and Alaranta 1988; Pohjolainen and Alaranta 1999;
Rommers et al. 1997; Wahlberg et al. 1994; Witso and Ronningen 2001). 
Table 1. The main causes of major lower limb amputation.
Cause % of amputations
Chronic critical leg ischaemia 70 - 90
Acute ischaemia 2.7 - 4.9
Diabetes mellitus 23 - 80
Tumour 1.5 - 3
Trauma 2 - 7
Miscellaneous  8 - 11
6.1.1 Nonvascular causes
Among traumatic lower limb major amputations, blunt injury, pulseless extremity, need for
arterial repair (rather than ligation or no therapy), increasing number of injured tibial
vessels and multiple long-bone fractures are predictors of amputation. Distal vascular
injuries combined with complex orthopaedic fractures are more likely to result in limb loss
(Moniz et al. 1997). The majority of all trauma-related amputations are performed on males
(Ebskov et al. 1994; Pezzin et al. 2000).
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In Finland, trauma caused 12% of all amputations in 1970 (Solonen and Huittinen 1991),
whereas in 1984-85 and 1995 the corresponding figures for Southern Finland  were 2%
and 4% respectively (Pohjolainen and Alaranta 1999). In a multicenter study, the
proportion of all major amputations associated with trauma was found to vary between 4%
and 10% in Europe and North America (Group TG 2000). However, one exception to this
was Newcastle, UK, where 15% of major amputations in women were associated with
trauma. The decrease in the number of amputations due to trauma may be largely
explained by improved industrial safety, improved methods of treatment of open fractures
and by advances in vascular and replantation surgery (Ebskov 1994; Ostrup and Vilkki
1986; Pohjolainen and Alaranta 1988).
The treatment of primary tumours, particularly osteosarcoma, has changed over the past
decades in terms of both medical and surgical care (Sweetnam 1991). About fourty years
ago, the majority of patients were treated by amputation (Sweetnam 1969; Sweetnam et
al. 1971), but the increasing number of cases treated by wide excision and the use of
adjuvant chemotherapy have decreased the number of amputations (Grimer et al. 2002;
Kavanagh et al. 1990; Sweetnam 1991). Despite the increase in the number of malignant
melanomas localised in the lower extremities, the annual number of major lower limb
amputations caused by this has remained constant (Ebskov 1993).
Deep infection, with or without concomitant vascular disease, usually affects diabetics.
Limb-threatening infection carries a 25% risk of major amputation (Gibbons 1987).
Approximately 1-4% of all major amputations are performed for deep infection without
knowledge of underlying critical leg ischaemia (CLI) (Benotmane et al. 2000).
Osteomyelitis without CLI caused 6 of 705 major amputations in Southern Finland during
the period 1984-85 (Pohjolainen and Alaranta 1988).
Other causes, such as congenital deformity and frostbite, account for a minimal
percentage of amputations (Alaranta et al. 1995; Laaperi et al. 1993; Pohjolainen and
Alaranta 1988; Pohjolainen and Alaranta 1999). In less-recent data in particular, the
proportion of ischaemia might have been underestimated due to the lack of systematic use
of non-invasive vascular diagnostics (Burgess and Matsen 1981).
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6.1.2 Atherothrombotic and other vascular causes
6.1.2.1 Atherothrombotic disease
Atherothrombotic arterial disease is a systemic disease affecting, in principle, all of the
arterial tree, with the predominance of carotid, coronary and lower limb vessels. The
clinical manifestations of atherosclerosis in different organs have been reported to occur
with different frequencies, but always with considerable overlap (Aronow and Ahn 1994;
CAPRIE Steering group 1996) (Figure 1). Chronic leg ischaemia is a gradually developing
process giving rise to symptoms caused by a reduced arterial blood flow. With worsening
flow, asymptomatic disease can progress through work-related pain to rest pain and tissue
loss. Claudication caused by relative arterial insufficiency has a benign prognosis with low
risk of limb loss, although mortality due to other atherosclerotic manifestations is high
(Bloor 1961; Dormandy et al. 1999d). In the historical study by Bloor and co-workers
during the period 1947-1953, critical leg ischaemia developed in 8.3% and 3.0% of the
claudicants in the first and third years respectively after diagnosis. Of these critically
ischaemic patients, 23-57% required major amputation (Bloor 1961). According to a recent
review by Dormancy and colleagues, only 1-3% of claudicants ever require major
amputation over a 5-year period (Dormandy et al. 1999d). Interestingly, it has been
demonstrated that a third of patients with CLI have no preceding claudication (Matzke and
Lepantalo 2001).
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Figure 1. Distribution of the three main manifestations of occlusive arterial disease.
CVD= cerebrovascular disease, CHD= coronary heart disease, PAD= peripheral arterial disease.
6.1.2.2 Critical leg ischaemia 
Atherosclerosis in the large arteries is the fundamental process in the pathogenesis of CLI.
Reduced arterial blood flow in a limb causing rest pain or tissue loss (ulcerations or
gangrene) represent CLI. CLI, with or without diabetes mellitus, accounts for 70-90% of
lower limb amputations (Group TG 2000; Pohjolainen and Alaranta 1988) and is a growing
problem in an ageing population demanding increasing vascular surgical resources (Luther
1994). 
In 10-40% of cases CLI leads to primary amputation (Dormandy et al. 1999b; Lepantalo
and Matzke 1996). As the outcome of CLI is so poor, the European Consensus Document
recommends revascularization for the treatment of CLI if there is more than a 25% chance
of patient survival and limb salvage for one year (Second European Consensus Document
1992).
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Although not substantiated by an adequate prospective study, the presence of gangrene
and ulceration (Fontaine IV) seems to be associated with a poorer prognosis than rest pain
alone (Fontane III) (European Consensus Document on CLI 1990). In the study by the
Joint Vascular Research Group in Britain (Wolfe 1986), patients with CLI who had
gangrene or ulceration were twice as likely to require a major amputation than those with
rest pain alone. Juergens and co-workers (Juergens et al. 1960) noted a 5-fold increase in
a similar group over a 5-year period. In their series of 465 patients the incidence of major
amputation was 19.8% for patients with ulcers or gangrene versus 3.8% for patients with
rest pain only. In patients with gangrene it has been assumed that almost all patients will
undergo amputation unless the circulation can be improved enough to achieve healing
(Luther 1997).
6.1.2.3 Acute ischaemia
Acute ischaemia requiring lower extremity amputation results most frequently from either
arterial thrombosis or embolism. The rare causes of acute lower limb ischaemia may be
related to anatomic causes, vasculitis, drugs, trauma and iatrogenic reasons (Lepantalo et
al. 2005). Despite the widespread use of the Fogarty thrombectomy catheter (Fogarty et
al. 1963), arterial bypass (Yeager et al. 1992) and catheter-directed thrombolytic infusions
(Ouriel 1996; Ouriel et al. 1994), the limb loss rate after acute ischaemia remains between
9% and 40% and mortality rates are up to 18% (Dormandy et al. 1999a; Kuukasjarvi and
Salenius 1994; Ouriel 1996; Yeager et al. 1992). 
6.1.2.4 Other vascular causes
Buerger´s disease (thromboangitis obliterans, TAO), although rare, is a clinical entity
which affects mostly young, male, inveterate tobacco smokers who present with distal
extremity ischaemia. The incidence of TAO is estimated to be 8-12/100 000 in North
America (Cooper et al. 2004). Patients with Buerger´s disease often suffer from severe
ischaemic pain and tissue loss culminating in major amputation in 12-30% of patients
(Cooper et al. 2004; Mills 2003; Mills et al. 1987; Shigematsu and Shigematsu 1999; Van
Damme et al. 1997). The risk of major amputation in TAO-patients is reported to be 11%
and 23% at 5 and 20 years respectively (Cooper et al. 2004). Vasculitis, such as
Takayasu´s disease and giant cell arteritis, leading to major amputation is extremely rare
17
in Finland (Johnston et al. 2002; Le Hello et al. 2001; Lepantalo et al. 2005; Vanoli et al.
2001). 
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6.2 Critical leg ischaemia 
6.2.1 Definition of CLI 
Chronic leg ischaemia is a gradually developing process giving rise to symptoms caused
by a reduced arterial blood flow. It is generally agreed that in critical leg ischaemia the
viability of the leg is endangered unless some improvement of the arterial supply is
undertaken, even if not all patients require major amputation. The Fontaine classification of
ischaemia defines four stages based on clinical symptoms (Fontaine et al. 1955). Stages
three and four, rest pain and tissue loss (ulcers or gangrene), represent the critical
ischaemic stage (Second European Consensus Document 1992). However, not all
patients with rest pain, ulcers or gangrene are under immediate threat of leg loss.
Therefore, more precise criteria for critical leg ischaemia have been developed. They are
based on both symptoms and objective pressure measurements as presented in Table 2.
(Ad Hoc Committee 1986; Rutherford et al. 1997; Second European Consensus Document
1992).
Table 2. Criteria for chronic critical leg ischaemia.
ankle pressure toe pressure Symptoms
European criteria 
(Eur cons doc 1992) ≤ 50 mmHg or ≤ 30 mmHg with
rest pain, ulcer or
gangrene
Criteria of the Ad Hoc
Committee < 40 mmHg or < 30 mmHg with Rest pain
(Rutherford 1997) < 60 mmHg or < 40 mmHg with Minor or major
 Tissue lost
These definitions produce a more objective tool for research purposes but at present no
definition criteria are able to correctly identify all limbs threatened by CLI. The problem in
defining critical leg ischaemia partly explains differing results achieved in the treatment of
CLI-patients. Additionally, each definition criterion has been questioned and challenged
mainly on the grounds that no definition has appeared to with any certainty predict the fate
of an individual patient regarding limb survival in the absence of active treatment
(Lundberg 2005).
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6.2.2 Incidence and prevalence of CLI 
Information on the incidence of CLI is sparse. CLI is difficult to assess on a population
basis, therefore all calculations are based on different  assumptions and projections.
Catalano (Catalano 1993) assessed CLI incidence in Italy using three different methods.
The results from the three approaches were substantially equivalent in order of magnitude,
giving the CLI incidence in a population aged over 45 as 450-652/million/year (Table 3).
Table 3. Incidence of critical leg ischaemia according to Italian data (Catalano 1993)
Annual incidence (per million inhabitants)
Population > 45 yrs CLI Major amputations Amputations
7-year follow-up of claudicants 450 112
Sample of hospital in Lombardy 652 160
Amputations in Lombardy 577 146 172
Amputations in Emilia Romagna 530 133 154
The Vascular Surgical Society of Great Britain concluded, based on the reports of a
national survey, that the annual incidence of CLI would be 400/million/year (The Vascular
Surgical Society of Great Britain and Ireland 1995). 
The incidence of CLI can also be extrapolated from the better-documented prevalence
studies of intermittent claudication (IC). These calculations are based on the assumptions
that occlusive arterial disease progresses from asymptomatic disease to claudication and
from claudication to rest pain and eventually to tissue loss. If one assumes that the overall
prevalence of claudication is 3% and that 5% of patients with IC will develop CLI over 5
years, this gives an incidence of CLI of 300/million/year (TASC 2000). These estimates,
however, exclude those asymptomatic patients who never experience claudication but
develop CLI (Dormandy et al. 1999d; Matzke and Lepantalo 2001). In a multicenter study
in Italy, 14% of critically ischaemic patients presented without preceding symptoms of
claudication (ICAI 1997). Therefore, the figures for prevalence or incidence calculated from
the prevalence of claudication appear to be too low.
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According to the TASC-document (TASC 2000), the CLI incidence can be calculated from
the number of major amputations. Assuming that 90% of major amputations are performed
for ischaemia and that only 25% of patients with CLI ever require a major amputation, it
can be calculated that the incidence of CLI is approximately 500 to 1 000/million/year.
According to a review covering 21 studies, the incidence varied 10-fold, with predictions of
100-1000/million/year (Heikkinen 2003).
Apart from the Italian and English studies mentioned above, there are no direct data on the
prevalence of CLI, but most cases either resolve or lead to amputation within a year, and
therefore the incidence and prevalence are similar. The Vascular Surgical Society of Great
Britain and Ireland suggested a prevalence of 400/million (1 in 2500) of the population
annually (The Vascular Surgical Society of Great Britain and Ireland 1995).
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6.2.3 Risk factors 
The risk factors for the development of CLI are largely the same as the risk factors for
peripheral arterial disease (PAD), although with a different weight of importance. The most
important risk factors for CLI are age, diabetes and smoking. Risk factors may contribute
to operative complications and influence patency, leg salvage and survival.
6.2.3.1 Age 
The prevalence of PAD increases rapidly with age (Criqui et al. 1985; Luther 1994; TASC
2000). Age is also associated with the progression of PAD to CLI (Dormandy et al. 1999e;
Murabito et al. 1997; Reunanen et al. 1982) as well as leg salvage and survival
(Zdanowski et al. 1998). Vascular surgeons are facing an ever-increasing number of aged
patients with CLI (Pomposelli et al. 1998). Major amputations are also more common in
the elderly (Group TG 2000; Liedberg and Persson 1983; Luther 1994; Pohjolainen and
Alaranta 1988). There is clear evidence that, despite shorter life expectancy and worse
general condition (Hearn et al. 1996; Nehler et al. 1993), even octogenarians can undergo
infrapopliteal bypass surgery (IPBS) safely, achieving graft patency and limb salvage rates
that are comparable to those achieved in younger patients (Luther and Lepantalo 1997a;
Luther and Lepantalo 1997b; Pomposelli et al. 1998). Several other authors also propose
an active reconstruction policy in elderly patients (Esato et al. 1993; Gouny et al. 1994;
Illuminati et al. 2000; Illuminati et al. 1999; Matsubara et al. 2001; McLoughlin et al. 1989;
Nehler et al. 1993; O'Mara et al. 1987; Scher et al. 1986).
In a Finnish study analysing the outcome of femoropopliteal reconstructions for CLI, the
percentage of patients achieving leg salvage up to three years or until death was similar in
CLI patients younger than 70 and in those over 70 years of age (Luther and Lepantalo
1996). In another study (Luther and Lepantalo 1997b) femorotibial reconstructions for CLI
were analysed. Neither increase in operative mortality nor any negative influence of age in
patency, leg salvage or survival was found.
To evaluate the effectiveness of arterial reconstructive treatment on CLI it is essential to
evaluate its impact on amputation rates in the population. With an increasing proportion of
patients with critical ischaemia in the age group of 80 or more years, it is important to
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determine separately if results in the oldest age group justify an active reconstruction
policy.
6.2.3.2 Diabetes 
Foot ulcers are a major problem in diabetes, affecting approximately 15% of all diabetics
during their lifetime (Gibbons and Eiopoulos 1995). Neuropathy seems to be the primary
factor provoking foot ulceration in diabetics, but lower limb ischaemia is the major factor
preventing wound healing (Lepantalo et al. 2000). The proportion of diabetic people
among individuals suffering from CLI is increasing. According to the 7-year data of a
nationwide vascular registry, Finnvasc, of 8250 patients treated for chronic critical leg
ischaemia, 4070 had diabetes. Their proportion increased from 46% in 1991 to 51% in
1997 (Mätzke 2004). Diabetic patients account for 40-70% of all lower extremity
amputations (Group TG 2000; International Consensus on the Diabetic Foot 1999) and
diabetes carries some 10-fold risk for amputation (Da Silva et al. 1996; Luther 1997; Morris
et al. 1998). On average, diabetics have to undergo amputation earlier than nondiabetics
(Morris et al. 1998). The majority of all diabetes-related major lower limb amputations
occur in patients with type II diabetes (Morris et al. 1998). The correlation between
diabetes and major amputation rates is independent of other risk factors, including age
and smoking (The Vascular Surgical Society of Great Britain and Ireland 1995). However,
smoking does appear to have an additive effect (Pell and Fowkes 1997).
6.2.3.3 Smoking 
Cigarette smoking increases both the risk of developing PAD and its progression (Da Silva
et al. 1979; Liedberg and Persson 1983). The risks associated with smoking apply to all
ages and increase with the number of cigarettes smoked (TASC 2000). Smoking is
present as a risk factor for CLI in 33-92% of all patients (Luther 1997). In multivariate
analyses too, smoking has been shown to be an independent risk factor (Liedberg and
Persson 1983; TASC 2000). Major amputation is more common among patients with
intermittent claudication (IC) who are heavy smokers and who continue to smoke
(Juergens et al. 1960; TASC 2000), the difference being as striking as 11% in smokers
and 0% in non-smokers within a 5-year study period (Juergens et al. 1960). In the Swedish
study there were considerably more current smokers among amputees than among age-
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and sex-matched controls, and smokers had a much lower mean age at amputation
(Liedberg and Persson 1983).
6.2.3.4 Gender 
Generally, men have a higher prevalence of PAD than women, with an overall male/female
ratio of 1.27 (Criqui 2001; Criqui et al. 1985). The female advantage disappears after
menopause (Kroger et al. 1999), as females are reported to develop PAD at older age
than males (Kannel and McGee 1985; Kroger et al. 1999; McDermott et al. 2003). Female
gender combined with diabetes has been observed to be associated with an adverse
outcome of revascularisation procedures in terms of graft patency and leg salvage (Luther
and Lepantalo 1997b).
6.2.3.5 Renal Insufficiency 
Chronic renal failure is associated with an increased risk of development of atherosclerosis
and its complications. Patients with end-stage renal disease have poor long-term survival,
with one and three-year survival rates of 72% and 39% respectively. (Harrington et al.
1990) Patients on long-term dialysis have a two-year survival rate of 23% (Biancari et al.
2002). Leg salvage, on the contrary, can achieve good results in patients with renal
insufficiency (Harrington et al. 1990; Korn et al. 2000; Peltonen et al. 1998), especially
patients in whom adequate autologous conduit is available (Meyerson et al. 2001).
However, as patient survival is poor for dialysis patients, a selective approach to
revascularisation in these patients is recommended (Harrington et al. 1990; Korn et al.
2000; Peltonen et al. 1998). In a study by Biancari et al (Biancari et al. 2002) the
amputation-free survival of CLI-patients on long-term dialysis and with coronary artery
disease was only 12% at one year and nil at two years. Therefore, in the presence of
coronary artery disease in dialysis patients, infrainguinal revascularisation hardly appears
to be indicated (Biancari et al. 2002). 
6.2.3.6 Other cardiovascular manifestations 
As the risk factors for PAD are similar to those for coronary artery disease (CAD) and
cerebrovascular disease (CVD), patients with PAD also have a high prevalence of CAD
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and CVD as co-morbidities, although the extent of co-morbidity depends on the sensitivity
of assessment (Criqui 2001). CAD is present in 31-75%, hypertension in 37-90% and CVD
in 5-25% of patients with CLI (Luther 1997). The main reasons for premature death of CLI
patients are the other manifestations of atherothrombotic disease, which cover 75% of
deaths of CLI patients (Dormandy et al. 1999b): CAD in 40-60%, CVD in 10-20% and
ruptured abdominal aortic aneurysm in 10% of cases (Luther 2003).
6.2.3.7 Infection 
Limb-threatening infections should be treated immediately and aggressively with
antibiotics, debridement and adequate drainage (LoGerfo and Marcaccio 1992). Ischaemic
tissue, especially in diabetics, is optimal ground for infections. Infection, on the other hand,
leads to microthrombus formation and thereby worsens the ischaemia by causing tissue
necrosis (Lepantalo et al. 2000). Aggressive treatment of infection with broad-spectrum
antibiotics and drainage is essential to prevent leg loss (Estes and Pomposelli 1996).
Biancari and colleagues (Biancari et al. 1999) have calculated that patients undergoing a
pedal bypass procedure with a serum level of C-reactive protein (CRP) above or equal to
100 mg/l have about a two-fold increase in risk for limb loss at one year. One important
factor is prompt patient referral: as many as 25-31% of eventual amputees may present
very late to the vascular surgeon with extensive gangrene or infection that precludes limb
salvage (Abou-Zamzam et al. 2003; Wahlberg et al. 1994).
6.2.3.8 Hyperlipidaemia 
The role of hyperlipidaemia as a factor associated with the development of PAD and its
progression has not gained the same interest as in cardiac or neurologic assessment
(Donnelly and Yeung 2002). The clinical management of peripheral vascular diseases
should include prevention of secondary cardiovascular complications, (e.g. assesment of
blood lipoprotein levels) which are often due to atherosclerotic plaque rupture leading to
thrombotic vessel occlusion (Donnelly and Yeung 2002). A dyslipidaemic serum profile,
characterisied by increased lipoprotein levels (Dionyssiou-Asteriou et al. 2000) and
decreased HDL-cholesterol levels (Dionyssiou-Asteriou et al. 2000; Fowkes et al. 1992),
has been shown to be associated with PAD. Two studies (Marcoux et al. 1996; Smith et al.
1996) have shown that, in multivariate analysis, hypertriglyceridaemia (≥ 2.2 mmol/l) was
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the only independent factor associated with deterioration of ankle-brachial pressure index
(ABI) and with the onset of CLI.
6.2.3.9 Thrombophilia 
Thrombophilia may be defined as the tendency to arterial or venous thrombosis.
Thrombophilia can be acquired or hereditary. With regard to arterial thrombosis, certain
thrombophilic disorders have a definite pathophysiological role (Bohm and Al-Khaffaf
2003; Burns et al. 2001; Vig et al. 2004). Hyperhomocysteinaemia, inherited or acquired,
has been demonstrated to be an independent risk factor for athero-thrombosis. The
antiphospholipid antibody syndrome (APS), an acquired condition, strongly predisposes to
arterial thrombosis. Other thrombophilic conditions, such as prothrombin gene G20210A
variant or factor V Leiden, have been investigated, but current evidence does not
unequivocally support the hypothesis of a pathophysiological role in athero-thrombosis
(Bohm and Al-Khaffaf 2003). The risk of thrombotic occlusion following arterial
revascularisation in patients with an identified thrombophilia defect appears to be almost
three times that of patients with no evidence of a thrombophilia defect (Vig et al. 2004).
Figure 2 summarises the features that predispose to the development of CLI and gives an
approximate risk assessment as illustrated by Dormandy et al (Dormandy et al. 1999e).
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Figure 2. The influence of different risk factors on the progression of PAD with subsequent
development of CLI (Dormandy et al. 1999e).
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6.2.4 Fate of a patient with critical limb ischaemia 
One and five-year mortality rates of patients with CLI are reported to be 20-25% and 40-
70%, respectively (Dormandy et al. 1999b; ICAI 1997; Wolfe and Wyatt 1997; Wolfe
1986). Within 10 years, 95% of CLI-patients representing with tissue loss and 80% of
patients with rest pain were dead (Dormandy et al. 1999b). The main causes of death for
CLI patients are cardiovascular (Luther 2003).
The reported primary amputation rates among patients with CLI vary between 10% and
40% (Dormandy et al. 1999b). The European working group on CLI estimated that one
year after the diagnosis of CLI, 55% of all patients would be walking on two legs, 20%
would be dead and 25% alive and have undergone amputation (Second European
Consensus Document 1992). The same document recommends revascularization for the
treatment of CLI if there is more than a 25% chance of patient survival and limb salvage
for one year.
Most patients with CLI nowadays undergo some form of revascularisation of the leg. Thus,
it is difficult to describe the natural history of a critically ischaemic limb. Patients not
suitable for active treatment are the only cases providing unmanipulated outcome data,
and do not represent the whole CLI group. A large proportion of these are patients whose
general condition is so poor, or whose atherosclerosis is so widespread, that arterial
reconstruction is not feasible (Heikkinen 2003). Lepäntalo and Mätzke (1996) studied the
outcome of CLI in 105 patients with 136 critically ischaemic legs treated conservatively.
One-year mortality was 54%, and at one year 46% of the critically ischaemic legs had
been amputated while 28% of the patients were alive with the nonamputated leg
(Lepantalo and Matzke 1996). In a study of 37 nonreconstructed patients with CLI,
Jivegård and his colleagues reported 35% to be alive at one year with the nonamputated
leg (Jivegard et al. 1995). The available data from conservative treatment series of CLI
patients thus gives amputation-free survival rates in the range 28-35% at one year
(Jivegard et al. 1995, Lepantalo and Matzke 1996) and 27% at two years (Klomp et al.
1999).
Dormandy and co-workers (Dormandy et al. 1999b) have summarised the outcome data of
different surgical and conservative series of CLI patients as shown in Figure 3.
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Primary amputation
25 %
Medical treatment 
only
25 %
Revascularisation
50 %
Cured
27 %
Alive amputated
26 %
Continuing CLI
21 % Dead
26 %
Figure 3. Initial treatment of patients with CLI and their status one year later according to
Dormandy and colleagues (Dormandy et al. 1999b).
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The fate of the limb is dependent on the degree of CLI. In the study by Bloor (Bloor 1961)
the risk for limb loss was 29% in patients with rest pain and almost 100% in patients with
ischaemic lesions. In a more recent review the risk for limb loss within a year in patients
with rest pain and tissue loss was estimated to be 70% and 95% respectively (Wolfe and
Wyatt 1997). The authors concluded that future reports should indeed identify these two
groups separately, as the dominant difference between outcome studies is the proportion
of subcritical patients (with rest pain, not always with a low ankle pressure) in the study
rather than better surgical or radiological techniques. Progression of the atherothrombotic
disease also results in a high incidence of CLI in the contralateral limb. Within 3-5 years
30-50% of those surviving may develop contralateral CLI symptoms (Luther 1997).
Because randomized prospective studies comparing long-term survival of patients after
revascularisation or major amputation are not possible, comparisons have to be
retrospective. These suggest a similar survival in patients undergoing either major
amputation or revascularisation (Dormandy et al. 1999b). Some studies have shown
shorter survival for patients undergoing amputation than for those with a salvaged leg:
Luther (Luther 1994) reported 1- and 5- year survival rates of 55% and 20% respectively
after major amputation and 83% and 45% respectively after reconstruction, but the
patients were not matched. Ouriel and colleagues (1988) found that survival was similar in
amputees with less severe co-existing medical illness, but amputees with severe medical
illnesses had a significantly worse perioperative mortality (16% vs 6% respectively) and 3-
year survival (29% vs 76% respectively) than those patients undergoing surgical
reconstruction (Ouriel et al. 1988). Whether this difference in survival rates is due to the
positive influence of reconstruction or only an expression of the varying severity of the
disease and selection of patients remains an unanswered question.
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6.3 Lower limb amputation incidence rates 
6.3.1 Crude incidence data 
In the Nordic countries the incidence of major lower limb amputations due to vascular
causes was 320/million inhabitants in 1979 in Malmöhus county, Sweden (Liedberg and
Persson 1983). The incidence of vascular amputations was 342 and 274/million
inhabitants in Varberg, Sweden, during the periods 1985-88 and 1989-92 respectively
(Karlstrom and Bergqvist 1997) and 160/million inhabitants in the catchment area of the
Karolinska Hospital (Wahlberg et al. 1994) during the period 1989-92. The incidence of all
major lower limb amputations was 409/million inhabitants during the period 1986-87 in the
county of Viborg in Denmark and 309/million during the period 1989-90 (Lindholt et al.
1994). Ebskov et al (1994) reported major lower limb amputation incidences of 345 and
250/million inhabitants in Denmark in 1983 and 1990 respectively. 
Tunis et al reported (1991) vascular lower limb amputation incidences of 280-320/million
inhabitants of Maryland, USA in 1979-1985, whereas Hallett and co-workers (1997)
reported amputation incidences of 367 and 190/million inhabitants of another community
(Olmsted County, Minnesota) in the USA between 1973-77 and 1988-92 respectively. In a
study by Feinglass and colleagues (Feinglass et al. 1999), the amputation rate was
250/million inhabitants in 1996 in the USA. Jones (1990) found the incidence of all
amputations in three Australian states to be 236/million in 1984 (Jones 1990) and Mattes
and colleagues (1997) reported the incidence of vascular major lower limb amputation to
be 103/million inhabitants in Western Australia during the period 1980-92. Rommers and
colleagues (1997) reported the incidence of all lower limb amputations to be 180-200
during the period 1982-1993 in the Netherlands. Pell and his co-workers (1994) reported a
vascular age-adjusted major amputation incidence of 142/million in 1990 in Scotland.
The incidence of all lower limb amputations in Southern Finland was 325-281, 220, 274
and 282/million inhabitants in 1984-85, 1989, 1992 and 1995 respectively (Alaranta et al.
1995; Laaperi et al. 1993; Pohjolainen and Alaranta 1988; Pohjolainen and Alaranta 1999).
In a nation-wide study in Finland, the overall incidence of major lower limb amputations
was 216 / million inhabitants per year in 1993-94 (Luther et al. 2000), varying from 140 to
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330/million inhabitants between different central hospital catchment areas. In the
Pirkanmaa region of Finland, the incidence of major lower limb amputations varied from
102 to 248/million inhabitants between the different subregions during the period 1990-
1999 (Heikkinen et al. 2002). Probably one of the lowest rates of incidence of major lower
limb amputation currently in Finland is found in the region of Vaasa central hospital, where
it was 108/million inhabitants during the period 1995-99 (Luther 2002). Previous rates for
this region were 317, 276 and 274/million inhabitants during the periods 1980-84, 1985-89
and 1980-91 respectively (Luther 1994; Luther et al. 1996).
In a multicenter study in Europe, North America and East Asia there were marked
differences in the overall incidence of all major amputations(Group TG 2000). However,
similar distributions by age and sex were demonstrated (Table 8). The highest rates for
men and women were in the Navaho area. The lowest rates for major amputation were in
the Japanese and Spanish centres. There were marked differences between European
centres. Rates in Madrid (Spain), Vicenza (Italy) and Leicester (UK) were substantially
lower than those in the north of England in Leeds, Middlesborough and Newcastle. In the
Navaho population, a very high prevalence of diabetes was likely to be the explanation for
the high amputation rates. Differences between other populations did not seem to be
related to the prevalence of diabetes; it seemed likely that differences in the prevalence of
peripheral vascular disease are important. Other factors, such as cultural and medical care
differences, including access to vascular surgery services, may also be important, but
require further investigation (Group TG 2000).
There are difficulties in comparing amputation rates in different studies. Inconsistencies
between published studies may relate to the inclusion or exclusion of all major
amputations performed for any reason (including other than vascular causes), inclusion or
exclusion of people with diabetes in the overall rates, of first-ever, or all, amputations and
differences in the level of amputations. In addition, age-specific rates tend not to be
presented, making comparison between populations with different age structures difficult.
Finally, different studies often use different data sources to identify amputations. It is
therefore possible that differences exist in the level of ascertainment of amputations
between studies (Group TG 2000)
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Table 4. Age-adjusted incidence* of all major
amputations in men and women 
Centre Men Women
Leeds, UK 199 102
Leicester, UK 56 43
Madrid, Spain 28 5
Middlesborough, UK 198 84
Montgomery, USA 192 170
Navaho area, USA 439 320
Newacastle, UK 163 88
Ilan, Taiwan 92 83
Tochigi, Japan 38 12
Vicenza, Italy 69 70
*Incidence per million inhabitants per year in a standard European
population according to the Global Lower Extremity Amputation
Study Group (Group TG 2000)
6.3.2 The changes in amputation incidence and vascular reconstruction policy 
It was noted in the 1980s that the frequency of lower limb amputations was increasing
(Liedberg and Persson 1983; Luther 1994; Pohjolainen and Alaranta 1988; Pohjolainen
and Alaranta 1999) and was predicted to increase even more in susbequent years with the
increase in life expectancy and size of the elderly population (Liedberg and Persson 1983,
Pohjolainen and Alaranta 1988, Pohjolainen and Alaranta 1999). The incidence was
predicted to increase 50% within the next 20-30 years as shown in Figure 4. (Pohjolainen
1991; Pohjolainen and Alaranta 1988).
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Figure 4. Future trend in the number of amputees (total and by age-group) in Finland estimated on
the basis of age-related incidences in Southern Finland 1984-1985 by Pohjolainen 1991.
Currently there is an ongoing controversy, often fuelled by unverified retrospective audit
data from large and changing populations (Mattes et al. 1997; Tunis et al. 1991), as to
whether there has been a significant reduction in amputations as a result of increasing
revascularization procedures in patients with CLI. Institutional reports have shown
excellent clinical patient outcome after arterial reconstruction (Tables 5 and 6), but these
reports may be misleading in the evaluation of the impact of treatment in the population, as
the analysis is skewed by selection bias in referral centres (Luther et al. 1996).
Tunis and colleagues (1991) found that from 1979 to 1989 the annual rate of PTA rose
from 10 to 240/million inhabitants in Maryland, USA. The annual rate of peripheral bypass
surgery also rose substantially, from 320 to 650/million inhabitants. Despite this, the
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annual rate of amputation remained stable at about 300/million inhabitants. In this study,
however, inclusion criteria were sparse, and the majority of patients treated with
revascularisation were claudicants.
A quite recent study of a fixed population in Varberg, Sweden, over 8 years strongly
suggests that a decrease in the primary amputation rate (from 42% to 27% in the
treatment of limb-threatening ischaemia), associated with a corresponding increase in
revascularisations, resulted in an overall decrease in the total amputation rate from 61% to
47% (Karlstrom and Bergqvist 1997). The incidence of vascular amputations was 342 and
274/million inhabitants in Varberg during the periods 1985-88 and 1989-92 respectively
(Karlstrom and Bergqvist 1997).
A decline in the major amputation rate has also been reported in a population-based study
made in Denmark; from 345/million in 1983 to 250/million in 1990 (Ebskov et al. 1994).
This decline coincided with an increase in vascular surgical activity of up to 100%,
including a marked rise in the rate of femorodistal reconstruction. Similar results were
obtained in another population-based study in Denmark (Eickhoff 1993): the number of
lower limb amputations in Denmark for peripheral occlusive arterial disease decreased
during the period of increasing vascular surgical activity from 1609 in 1983 to 1181 in
1990. 
Activity within one District Health Authority in England has been compared for the periods
1983 to 1987 and 1988 to 1991. There was an 11-fold increase in surgical reconstructions
and a 13-fold increase in endovascular procedures. This was accompanied by a 32%
decrease in the annual rate of major amputations from 480 to 320/million inhabitants
(Gutteridge et al. 1994).
A study from a defined community in the USA reported that major amputation rates
decreased by 50% between 1973-77 and 1988-92 from 367/million inhabitants during the
first study period to 190/million inhabitants during the second (Hallett et al. 1997). This
coincided with a significant increase in vascular surgery and balloon angioplasty.
In a careful longitudinal study of a well-defined and reasonably stable population in Finland
from 1970 to 1991, Luther (Luther 1994) showed a 2.5-fold increase in major amputations
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for ischaemia from 120 in 1970 to 300/million inhabitants in 1981. The increase in numbers
of reconstructions for CLI by 100% from 1980 onwards was associated with a reduction in
amputation rate of 60% from 1983 to 1991 (being 120/million inhabitants in 1991), despite
a significantly ageing population. 
Finally, a nation-wide two-year analysis from Finland (Luther et al. 2000) showed an
inverse correlation between the incidence of infrapopliteal surgical reconstructions and that
of BK amputations in different hospital regions 
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6.4 Vascular surgery – impact on amputations 
Two main open vascular surgical options are available in the treatment of patients with
CLI: a vein or artifical conduit can be used to bypass the diseased vessel or, alternatively,
stenosing or occluding plaques can be surgically removed – thrombendarterectomy
(Lundberg 2005). The extensive vascular disease in CLI generally precludes more limited
interventions and is why a bypass procedure is by far the most common surgical operation
performed (Lundberg 2005). Advances in surgical technique have greatly increased the
number of vascular reconstructions done. The majority of patients with CLI have
multisegmental disease with occlusions longer than 10 cm (Bradbury 2003; Salas and
Bolia 2003), and an increasing proportion are diabetics whose arterial disease primarily
affects the infrapopliteal arteries (Da Silva et al. 1996). Reconstructions for CLI originate
below the inguinal ligament in 65-83% of patients (Salenius et al. 1993; The Vascular
Surgical Society of Great Britain and Ireland 1995), and in all legs in need of infrainguinal
reconstructions the majority have arterial occlusions necessitating infrapopliteal
reconstructions (Gibbons and Eiopoulos 1995; Leather et al. 1988; Shearman et al. 2000). 
It was shown in a nation-wide study by Luther and colleagues (2000) that increasing the
number of infrapopliteal surgical reconstructions for CLI results in a reduction in below-
knee-(BK-)amputation. In infrapopliteal reconstructions, autologous vein should always be
used when possible due to higher graft patency (Shearman et al. 2000). The autologous
long saphenous vein can be used in-situ or reversed with apparently good results (Akbari
et al. 2000; Harris et al. 1993; Pomposelli et al. 1995; Sayers et al. 1998). The merit of the
reversed method is that both proximal and distal anastamoses can be performed
synchronously, reducing operation time, whereas the in-situ technique allows the smaller
distal end of the vein to be anastamosed to the smaller run-off artery (Shearman et al.
2000). Over the last decades, several centres have put a great deal of effort into
infrapopliteal bypass surgery (IPBS) for leg salvage in CLI (Tables 5 and 6). This
increasing reconstruction activity has also been supported by studies showing that the
patient’s quality of life is reduced after an amputation (Albers et al. 1992; Pell et al. 1993).
In the surgical series of distal reconstructions, major amputation rates ranging from 2% to
34% at 1 year and 12% to 36% at 2 years have been reported (Tables 5 and 6).
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Some amputations have been prevented by combining long bypass surgery with
microvascular free flap transfer. In addition to anecdotal reports, only four series with life-
table analysis on leg salvage are available (Czerny et al. 2004; Moran et al. 2002;
Tukiainen et al. 2000; Vermassen and van Landuyt 2000).
38
Table 5. Outcome of reconstructions for CLI to crural arteries.
Leg salvage (%) Survival (%)
Legs DM (%) FIV (%) ABI 1m 1y 2y 3y 5y 1m 1y 2y 3y 5y
Leather et al. 1988 10381 - - - - - - - - 93 - - - -
Hickey et al. 1991 239 24 - - - - - - - 93 81 - 62 60
Anderson et al. 1992
96 (ATA)2
65 (ATP)2
67 (AP)2
- - -
95
97
88
90
80
78
-
85
78
74
- - - - - -
Synn et al. 1992 53 53 6 CLI5 - 81 81 - - 92 - - - -
Bergamini et al. 1994 77 (AP)2 56 52 0.32 96 76 73 - - 82 77 69 51
Darling et al. 1995 732 (AP)2 - - - 96 96 - - 93 96 - - - -
Abou-Zamzam et al. 1996 159 69 52 0.41 - 86 86 - - - 60 60 60 -
Luther & Lepäntalo 1997b 209 47 61 - - 814 - 764 714 - - - - -
Eslami et al. 1997 130 59 51 0.54 97 - - - 79 - - - - 55
Sayers et al. 1998 635 36 - - - 81 73 - - - 84 74 - -
Biancari et al. 1999 77 45 58 0.32 94 80 76 76 - 92 83 82 76 -
Van Damme et al. 2003 903 43 57 - - - - - 89 - - - - 67
DM = diabetes mellitus. FIV = Fontaine IV disease. ABI = ankle brachial index (mean). ATA = arteria tibialis anterior. ATP = arteria tibialis posterior. AP = arteria peronealis.
1 88% CLI.
2 in situ vein.
3 includes four legs with claudication.
4 prosthetic grafts excluded
5 stated, that pressure measurements fullfilled CLI criteria, but ABI not given
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Table 6. Outcome of reconstructions for CLI to pedal arteries.
Leg salvage (%) Survival (%)
Legs DM (%) FIV (%) ABI 1m 1y 2y 3y 5y 1m 1y 2y 3y 5y
Anderson et al. 1992 231 - - - 92 74 - 68 - - - - - -
Tannenbaum et al. 1992 562 100 100 - 100 98 - 98 - 98 95 - 83 -
Bergamini et al. 1994 175 74 78 0.35 93 77 74 - - - 82 77 69 51
Gloviczki et al. 1994 100 - - 0.55 95 85 - 79 - 100 90 - 83 -
Darling et al. 1995 2381 - - - 95 94 - - 86 94 - - - -
Pomposelli et al. 1995 384 95 90 - 98 94 - 92 87 98 90 - 75 57
Shah et al. 1995 106 78 - - 98 93 - 93 93 97 - - - 47
Abou-Zamzam et al. 1996 46 70 100 0.43 - 70 70 70 - 98 84 75 69 -
Luther and Lepäntalo 1997a 109 74 84 0.43 87 66 64 - - 96 80 69 54 -
Biancari et al. 1999 165 70 84 0.46 88 66 66 60 - 95 75 69 55 -
Akbari et al. 2000 9623 83 89 - - - - 87 - - - - 58
Biancari et al. 2000 664 79 89 CLI5 97 88 88 - - 94 - 72 - -
DM = diabetes mellitus. FIV = Fontaine IV disease. ABI = ankle brachial index (mean).
1 in situ vein
2 diabetes with infection
3 includes 58 legs with claudication and 18 asymptomatic legs with failing grafts
4 includes 18 crural grafts
5.stated, that pressure measurements fullfilled CLI criteria, but ABI not given
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6.5 Endovascular procedures – impact on amputations 
Since the first description in 1964 (Dotter and Judkins 1964), percutaneous transluminal
angioplasty (PTA) has played an increasingly important role in the treatment of peripheral
vascular disease (Nasr et al. 2002; Pell et al. 1994). The role of PTA in treating CLI
patients has become an issue of increasing interest, but also a source of controversy
(Bradbury et al. 2002; Bradbury and Ruckley 1996).
According to the TASC document only 5-35% of patients with CLI would be candidates for
angioplasty if the selection is made by ”favourable anatomy” (TASC 2000), which in
general terms means only stenotic lesions or short occlusions. There is a lot of evidence
that PTA is highly effective in treating patients with peripheral arterial disease involving the
aorto-iliac system (Parsons et al. 1998). However, in the treatment of CLI, the
effectiveness of PTA remains controversial when arterial segments below the inguinal
ligament are involved, with one-year patency ranging from 12% to 88% (Parsons et al.
1998; TASC 2000; Varty et al. 1998). In addition, the majority of patients with CLI have
multisegmental disease with occlusions longer than 10 cm. Yet it has been suggested that
the technique of intentional subintimal recanalisation / angioplasty, first described by Bolia
and his associates, would be the endovascular solution to treat them (Bolia et al. 1989;
Bolia et al. 1990; London et al. 1994; Reekers and Bolia 1998).
The results of PTA in treating critical limb ischaemia during the 1980s and 1990s were
mainly fairly poor (Bradbury 2003). Limb salvage rates for the patients treated varied from
50% at 5 months (Zarins et al. 1980) to 56% at one year (Matsi 1995). 
Recent papers reporting on the results of infrainguinal angioplasty as treatment for CLI
patients show excellent limb salvage rates of up to 91% at 5 years (Boyer et al. 2000;
Dorros et al. 2001; Faglia et al. 2002; Jamsen et al. 2002; Nasr et al. 2002) (Table 7).
Interestingly, many studies reported high limb salvage and clinical improvement rates (72-
89% in 2-3 years), regardless of the patency rates (Boyer et al. 2000; Lofberg et al. 1996;
London et al. 1995).
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Table 7. Outcome of infrainguinal angioplasty for CLI.
Leg salvage (%) Survival (%)
Legs DM (%) FIV (%) ABI 1m 1y 2y 3y 5y 1m 1y 2y 3y 5y
Zarins et al. 1980 6 - 100 0.2 - 50 - - - - - - - -
London et al. 1995 54 49 63 0.431 - - 89 - - - - 76 - -
Matsi et al. 1995 117 77 76 - 77 56 49 49 - 91 70 - - -
Löfberg et al. 1996 86 - 98 0.3 - - - 72 - - - - - -
Parsons et al. 1998 257 63 - - - - - - - - - - - -
Varty et al. 1998 84 - - - 82 76 - - - 94 78 - - -
Boyer et al. 2000 492 73 59 343 100 87 87 872 - 100 92 81 75 -
Dorros et al. 2001 2844 62 43 CLI7 - - - - 915 - 90 86 78 56
Löfberg et al. 2001 92 43 75 0.3 - - - - 866 96 - - - 51
Faglia et al. 2002 221 100 100 0.53 - 95 - - - - 95 - - -
Jamsen et al. 2002 116 76 80 CLI7 - - - 65 60 - - - 41 26
Matsagas et al. 2003 50 50 - 0.4 - 98 - - - 96 73 67 59 -
Molloy et al. 2003 133 39 69 - - 88 - - - - 76 - - -
DM = diabetes mellitus. FIV = Fontaine IV disease. ABI = ankle brachial index (mean).
1 56% of patients with ankle pressure > 50 mmHg
2 at three years only nine limbs at risk
3 mean ankle pressure in nondiabetics and toe pressure in diabetics
4 not on intention-to-treat basis
5 18 limbs with bypass included
6 limb salvage for combined endovascular and vascular interventions
7. stated, that pressure measurements fullfilled CLI criteria, but ABI not given
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There are even centres with a policy of treating the majority of CLI patients with
(subintimal) angioplasty, based on their understanding that the results of subintimal
angioplasty could be superior to surgery (Molloy et al. 2003; Varty et al. 1998). There have
been, however, criticisms brought against the reports from the Leicester group (Bradbury
2003), as other studies have shown poor long-term patency rates with subintimal
angioplasty (Laxdal et al. 2003; Tisi et al. 2002; Yilmaz et al. 2003). It has been pointed
out that it remains difficult to explain why the Leicester group´s experience is so uniquely
favourable both in terms of the number of patients who appear suitable for the technique,
the immediate technical success rate and the complication rate and medium-term
durability (Bradbury 2003). While exceptional interventional skill is probably a factor, it
seems likely that a significant proportion of the Leicester patients had subcritical limb
ischaemia (Wolfe and Wyatt 1997) as opposed to true CLI (Bradbury 2003). Yet, very
recent data from other centres confirms the good results of the Leicester group in treating
CLI with subintimal angioplasty (Reekers 2002; Spinosa et al. 2004).
6.5.1 Comparison of endovascular treatment with vascular surgery in the treatment
of CLI
There are two nation-wide studies comparing the results of surgery versus PTA in treating
CLI patients (Luther et al. 2000; Zdanowski et al. 1998). Zdanowski and co-workers
reported (1998) from Sweden that the outcome of these two treatment modalities was
similar regarding amputation, whereas, in contrast, the study by Luther et al. (2000) in
Finland favoured infrapopliteal bypass operations. Both studies were population-based
and with groups that were by no means comparable.
The Cochrane Database of systematic reviews has accepted two prospective randomised
trials comparing bypass operations and PTA among CLI patients (Holm et al. 1991; Wilson
et al. 1989). Pooling both trials showed no overall significant difference in amputation rates
between the surgery and PTA groups (OR 1.48, 95% CI 0.79, 2.77). These findings must,
however, be viewed with caution, as only iliaco-popliteal lesions were included in these
two studies. Patients with multilevel disease, or those requiring tibial or pedal artery
bypass, would not be eligible for angioplasty, so the trials include only a subset of patients
with CLI. Randomisation of CLI-patients to either of these two treatment modalities can,
indeed, be difficult (Holm et al. 1991). In this particular study, although it may seem
historical from the perspectives of today´s practices, only 5% of patients were eligible for
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either treatment modality. Thus no generalisation is possible, as 95% of patients were
exluded. Proper randomised controlled trials require a large number of patients with easily
definable inclusion criteria. The major problem related to lower limb occlusive changes is
the multitude of anatomic varieties and therefore poor comparability, which is illustrated by
the attempts to classify lower extremity arterial disease (TASC 2000).
As has been stated in some reports (Boyer et al. 2000; Doubilet and Abrams 1984;
Lofberg et al. 2001; Matsagas et al. 2003), failure after attempted endovascular
revascularisation rarely compromises a subsequent surgical bypass option, which may
support the use of endovascular techniques in cases of uncertainty.
To date, there is no evidence-based data (level I) to support systematically either modality
as a first-line treatment for CLI (Bradbury 2003). The same patients may receive entirely
different treatment depending on which hospital they attend and which consultant they see
(Bradbury et al. 2002). Results from the Bypass versus Angioplasty in Severe Ischaemia
of the Leg (BASIL)-trial from the United Kingdom will hopefully give us more information on
this matter (Bradbury et al. 2002).
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6.6 Management of the diabetic foot – impact on amputations 
The incidence of diabetes mellitus is increasing worldwide. The incidence of type I
diabetes in Finland was 36.5 /1000 000 in the year 2000, and is predicted to be 50 /100
000 by the year 2010 (Onkamo et al. 1999; Steck and Rewers 2004). Accordingly, a rising
trend in the prevalence of type II diabetes has also been reported in Finland (Laakso et al.
1991). The statistics of the Social Insurance Institution of Finland showed that, at the end
of 1990 and 2002, 100 023 and 145 731 diabetic patients respectively were entitled to
reimbursements of their medical expenses, thus presenting a 53% increase in 12 years.
Both increased incidence and decreased mortality among diabetic subjects have
contributed to the increased trend in the prevalence of diabetes (Laakso et al. 1991). 
Ischaemic foot ulceration in the diabetic patient is a source of great physical and emotional
stress to the patient and represents a significant burden for the health care system and
costs to the payer (Gibbons et al. 1993; International Consensus on the Diabetic Foot
1999; Kellicut et al. 2003). Approximately 15% of patients with diabetes will have a foot
ulcer (Gibbons and Eiopoulos 1995), and 85% of all diabetes-related lower extremity
amputations are preceded by a foot ulcer (International Consensus on the Diabetic Foot
1999). The most important factors related to the development of foot ulcers are peripheral
neuropathy, minor foot trauma and foot deformities. The severity of lower extremity
arteriosclerosis, on the other hand, is the main independent risk factor for major
amputation (Faglia et al. 1998; Lepantalo et al. 2000). Diabetic patients account for 40-
70% of all lower extremity amputations (International Consensus on the Diabetic Foot
1999; Mätzke 2004). The prevention, assessment, and treatment of diabetic foot ulcers
and CLI has, fortunately, improved in recent years.
6.6.1 Multidisciplinary foot care team approach
The implementation of a multidisciplinary team approach in the prevention and treatment
of diabetic foot ulcers has been reported to be an effective means of preventing
amputations in the diabetic patient (Edmonds et al. 1986; Gibbons et al. 1993; Holstein et
al. 2000; Larsson et al. 1995; Morris et al. 1998; van Houtum et al. 2004). Using a
multidisciplinary team, which preferably consists of an internist, podiatrist, orthopaedic or
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plastic surgeon and vascular surgeon, rehabilitation physician, orthopaedic shoemaker,
and diabetes specialist nurse (van Houtum et al. 2004), a reduction in amputations as high
as 50-85% has been described (Larsson et al. 1995; van Houtum et al. 2004). In a
population-based study by Larsson et al (1995), the incidence of diabetic major
amputations decreased by 78% from 160 / million inhabitants in 1982 to 36 / million
inhabitants in 1993 in the Lund University Hospital catchment area in Sweden. In 1983, a
multidisciplinary diabetic foot team was established in the area. However, a considerable
decrease was also noted in amputations for vascular disease without diabetes. There is
one published nation-wide analysis of the incidence of diabetes-related lower limb
amputations, and it shows a 36% decrease in amputations in men and a 38% decrease in
women with diabetes in the Netherlands over the period 1991-2000 (van Houtum et al.
2004). The impact of vascular surgery or a diabetic-foot team as a whole on these figures
was not truly analysed. In addition, all lower limb amputations were included in the
analysis. Likewise, in a nation-wide study from Finland, the number of first amputations at
any level in diabetic people decreased from 767 to 385 per 100 000 diabetics from 1989 to
2002 (Winell 2005).
6.6.2 Diabetes and the outcome of infrainguinal reconstructions for CLI
The operative management of CLI has undergone an evolution over the last 3 decades.
Diabetic people, in contrast to those without diabetes, often have a pattern of
atherosclerotic vascular disease which spares the superficial femoral and popliteal
arteries. The crural vessels, on the other hand, show occlusions of variable extent, while
the pedal vessels remain patent (Da Silva et al. 1996). Despite decreased survival among
diabetics (AhChong et al. 2004; Luther and Lepantalo 1996; Luther and Lepantalo 1997b;
Wolfle et al. 2003), there is strong evidence that bypass grafting to the leg is worthwhile
(Akbari et al. 2000; Pomposelli et al. 1990; Pomposelli et al. 1995; Sayers et al. 1994;
Sayers et al. 1993; Wolfle et al. 2003). Holstein and collegues (2000) reported that the
incidence of major amputations in patients with diabetes decreased from 272/million
inhabitants in 1981 to 69 / million inhabitants in 1995 in Copenhagen, Denmark. At the
same time, infrapopliteal arterial bypass was introduced for the treatment of CLI, and in
diabetic patients the number of these bypasses increased from 0 to 130/million inhabitants
(Holstein et al. 2000).
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Patency rates and limb salvage rates after infrainguinal revascularization in diabetic and
non-diabetic patients have been reported to be equal (AhChong et al. 2004, Akbari et al.
2000, Luther and Lepantalo 1996, Pomposelli et al. 1990; Pomposelli et al. 1995, Wolfle et
al. 2003). A combination of female gender and diabetes has been shown to have a
negative influence on patency and leg salvage (Luther and Lepantalo 1997b). 
In a nation-wide analysis of diabetes as a risk factor for postoperative mortality and
morbidity after surgery for CLI in Finland during the period 1991-1999, diabetes was found
to be an independent risk factor for postoperative BK amputation (Virkkunen et al. 2004).
The acute graft occlusion rate was equal for diabetics and nondiabetics, emphasising the
independent role of diabetes in increasing the risk of amputation (Virkkunen et al. 2004). In
cases in which the graft was patent at 30 days, significantly more diabetics than
nondiabetics underwent amputation, supporting the suggestion that in diabetics
reconstruction is often performed too late, and that diabetics more commonly must
undergo amputation due to major tissue loss, despite successful revascularisation
(Virkkunen et al. 2004).
In general, published papers do not reveal what the exact role of a multidisciplinary foot-
care team has been in decreasing amputation figures.
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6.7 Conservative treatment – impact on amputations 
Conservative treatment for CLI is recommended only in patients with unreconstructable
arterial changes, when there are contraindications to reconstruction or as a temporary
treatment while planning for reconstruction (Luther 1997). Series assessing the outcome in
patients unsuitable for revascularisation, or with failed bypass attempts, report major
amputation rates ranging between 32-50% at six months of follow-up (Klomp et al. 1999;
Norgren et al. 1990; The U.K. Severe Limb Ischaemia Study Group 1991). Only a few
studies have a follow-up longer than six months. In a study by Lepäntalo and Mätzke, the
amputation rate at 12 months was 46% (Lepantalo and Matzke 1996). In a study by
Jivegård et al, the amputation rate at 18 months was reported to be 54%, as was the major
amputation rate at 24 months in a study by Klomp and co-workers (Jivegard et al. 1995;
Klomp et al. 1999) (Table 8).
Table 8. Outcome of critical leg ischaemia with conservative treatment.
N DM (%) FU(months)
Mortality
(%)
Major
amputations (%)
Norgren 19901 53 34 6 15 45
UKSLISG 19911 71 49 6 11 47
Jivegård 19952 26 19 18 30 54
Klomp 19992 60 38 24 68 54
Lepäntalo & Mätzke 1996 105 50 12 54 46
N = number of patients. DM = diabetes mellitus. FU = Follow-up. UKSLIG = UK Severe Leg
Ischaemia Study Goup.
1 Randomised studies with prostanoid treatment.
2 Randomised studies with epidural stimulation as treatment.
The impact of pharmacological therapies on the outcome of CLI has proved to be limited.
Prostanoids (intravenous Iloprost or prostaglandin E1) seem to be a treatment with some
effect on rest pain and healing of ischaemic ulcers for a short period of time (ICAI 1997;
Norgren et al. 1990; The U.K. Severe Limb Ischaemia Study Group 1991). In two
randomised and placebo-controlled studies, an oral prostacyclin analogue (Iloprost)
showed no clear benefit in patients with CLI (The Oral Iloprost in severe Leg Ischaemia
Study Group 2000). The TransAtlantic Inter-Society Consensus (TASC) for the
management of peripheral arterial disease recommends the use of prostanoids in patients
who have a critically ischaemic yet still viable limb in which revascularisation procedures
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are impossible, carry a poor chance of success or have previously failed, and particularly
when the alternative is amputation (TASC 2000).
For patients with CLI, electrical spinal cord stimulation (SCS) has been advocated for the
treatment of ischaemic pain and the prevention of amputation. However, there are only two
carefully planned prospective randomised controlled trials testing this hypothesis (Jivegard
et al. 1995; Klomp et al. 1999). In a rather small study, Jivegård and colleagues (1995)
reported SCS to provide long-term pain relief, but limb salvage at 18 months was not
significantly improved by SCS. In a study by Klomp and colleagues (1999), 120 patients
with CLI, but not suitable for reconstruction, were randomly assigned either to SCS plus
the best medical treatment or to the best medical treatment alone. SCS did not prevent
amputation in the study. Thus, SCS should be used only when all possibilities for
revascularisation have been excluded and probably only in selected cases (Klomp and
Steyerberg 2005).
It was previously assumed that all patients with severe ischaemia would at some stage
require major amputation if not treated surgically or radiologically. Although data
concerning the natural history of the conservative treatment of CLI is sparse (Second
European Consensus Document 1992), it is known that a proportion of these limbs do not
progress to amputation. In some instances conservative or medical treatment may be
sufficient. There appears to be a less severely affected group of CLI patients with so-called
subcritical ischaemia (tissues intact and ankle pressure of >40 mmHg) in whom limb loss
does not appear to be inevitable, and pharmacotherapy or conservative treatment may buy
sufficient time for the crisis to pass (Wolfe and Wyatt 1997), especially if revascularisation
appears to have risks. On the other hand, there is no evidence that the use of some mode
of conservative treatment could improve limb salvage for the high risk group of CLI
patients with tissue loss and /or ankle pressure < 40 mmHg (Wolfe and Wyatt 1997).
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6.8 Amputation in the treatment of CLI
In some vascular patients amputation is the only option to relieve pain and remove a non-
healing infected limb. If an ischaemic and infected leg or gas- or septic gangrene causes
an immediate threat to a patients´s survival, an immediate major amputation is mandatory
(TASC 2000). Unreconstructable arterial disease is generally due to the progressive
nature of the underlying atherosclerotic occlusive condition. There is still a group of
vascular patients, though a diminishing one, with limb vasculature unsuitable for a
revascularisation procedure or whose leg condition (because of widespread gangrene or
vast infection) makes the leg unsalvageable (TASC 2000). It was estimated by Shearman
et al in 2000, that in 10% of patients it will be deemed technically impossible to
revascularise the limb, or the procedure will fail (Shearman et al. 2000). Critical leg
ischaemia of bed-ridden patients should be treated by amputation at a sufficiently high
level to avoid healing problems (Luther 1997). PAD-patients with terminal or near-terminal
co-morbidities will not gain any benefit from revascularisation procedures either, as the
combination of leg salvage and survival is so poor (Biancari et al. 2000; Humphreys et al.
1995; Johnson et al. 1995). Primary amputation may be the best choice in these patient
groups (Johnson et al. 1995, Luther 1997) if amputation is needed (Wolfe and Wyatt
1997). 
Secondary amputation is indicated when vascular intervention is no longer possible or
when the limb continues to deteriorate despite the presence of a patent reconstruction
(TASC 2000). In different series, the proportion of cases in which revascularisation had
been attempted prior to amputation varies between 23% and 97 % (Holdsworth 1997; ICAI
1997; Luther 1994; Taylor et al. 1991). The most common indication for secondary
amputation is bypass thrombosis, accounting for nearly 50% of such cases (Reifsnyder et
al. 1997; Wahlberg et al. 1994). Failure of limb salvage despite patent bypass is the
second common indication (Reifsnyder et al. 1997).
Decisions on whether to perform revascularisation or amputation in a given patient are
multifactorial and must include an estimate of operative risks, the probability of successful
revascularisation, the potential gain from successful revascularisation and the patient´s
own wishes. Whatever the decision, all patients with CLI should be seen by a vascular
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surgeon before amputation is recommended (Lepantalo et al. 2000; Shearman et al. 2000;
Wahlberg et al. 1994).
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6.9 Fate of an amputee 
There is rather limited information on the rehabilitation of patients who have undergone
amputation in Finland. Epidemiological trends for lower limb amputees have, however,
been studied in Southern Finland in four surveys for the years 1984-1995 (Alaranta et al.
1995; Laaperi et al. 1993; Pohjolainen and Alaranta 1988; Pohjolainen and Alaranta 1999).
Trends for amputees in the study area in four previous surveys are shown in Table 9.
Table 9. Trends in the amputees in four previous surveys from Southern Finland.
1984-1985 1989 1992 1995
Incidence per million
inhabitants 325 - 281 220 274 282
BK / AK -ratio 0.54 0.57 0.78 0.95
Mortality - unilateral - 2 mo1
         AK 32% 28% 32% 28%
         BK 17% 16% 19% 17%
Mortality - all - 1 yr2 39% 36% 37% 40%
BK = below-knee amputation. AK = above-knee amputation.
1 Mortality during the first two postoperative months among unilateral amputees.
2 Mortality of all amputees during the first postoperative year.
The below-knee amputee walking with a prosthesis expends 25% to 40% more energy
than in normal walking. In contrast, the above-knee amputee walking with a prosthesis
expends  65% to 100% more energy than normal (Meier 2000). According to the literature,
approximately 70% of patients with BK-amputation and 10-30% of patients with AK-
amputation will walk with a prosthesis (Krupski 2000). After bilateral amputation, 10-25%
of patients with AK- and BK-amputation will walk, but after bilateral AK-amputation, the
wheelchair becomes the only practical method of achieving mobility, if mobility can be
realistically achieved at all (Meier 2000). Much lower figures for rehabilitation of amputees
have also been presented: at a Veterans Affairs hospital in a series of 229 patients with
major amputation, 65% of BK-amputees and 80% of AK-amputees were not able to walk
after amputation during a 7-year study period in 1994-2001 (Cruz et al. 2003). In a study
by Houghton and colleagues in England, 440 vascular amputations during a two-year
study period were assessed. Thirtyone percent of the amputees received a prosthesis, 10-
15% achieved mobility at home, but only 5% rehabilitated well and became independent of
their wheelchair (Houghton et al. 1992). 
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Generally, two to three times more BK amputees achieve full mobility than AK amputees
(Cruz et al. 2003; Dormandy et al. 1999c; Turney et al. 2001). Received wisdom
commends a policy of maximizing the ratio of BK- to AK- amputations in patients with end-
stage arterial disease. A BK / AK-ratio greater than 1 has been reported in many series
(Aulivola et al. 2004; Campbell et al. 1994; Christensen and Klarke 1986; Cruz et al. 2003;
Gutteridge et al. 1994; Hallett et al. 1997; Houghton et al. 1992; McWhinnie et al. 1994;
Morris et al. 1998; Turney et al. 2001). According to some researchers the BK/AK-ratio
should be closer to 2 than 1 (Dormandy et al. 1999c), although the TASC Document is
pleased with 1 (TASC 2000). Opposite views have also been taken: McWhinnie and
colleagues (McWhinnie et al. 1994) concluded that increasing the proportion of BK-
amputations from one-third to two-thirds of lower limb amputations for occlusive arterial
disease did not improve effective rehabilitation rates; instead it appears that a patient will
derive more rehabilitation potential from a good AK-amputation than a marginal BK-
amputation.
Early hospital mortality rates after BK-amputation range in most series from 3% to 14%,
whereas the hospital mortality after an AK-amputation ranges from 3% to 35% (Aulivola et
al. 2004; Cruz et al. 2003; Houghton et al. 1992; TASC 2000). This is thought to be due to
allocating the older and high-risk patients who have little prospect of rehabilitation to the
AK-amputee group (Aulivola et al. 2004; Cruz et al. 2003). However, several reports have
related operative mortality to a coexisting medical condition such as diabetes and
cardiovascular, cerebrovascular and respiratory disease and found no significant
correlation (TASC 2000). In two years, mortality rates of 25% to 35% for BK- and 45% for
AK-amputees are seen (TASC 2000), and it appears that the mortality for amputations
associated with this high-risk group has remained essentially unchanged over the past 30
years (Cruz et al. 2003; Kazmers et al. 2000). After BK-amputation 50% of patients are
dead within 5 years, 30% of patients will undergo a contralateral major amputation and
20% will be alive with the contralateral leg intact (Dormandy et al. 1999c). In other words,
the survival probabilities at 7.5 years for BK-amputees and AK-amputees are 28% and
20% respectively (Cruz et al. 2003).
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7. AIMS OF THE PRESENT STUDY
The main purpose of this study was to evaluate the changing trends in the incidence and
outcome of major amputation in two well defined areas as well as the impact of
infrainguinal reconstructions and percutaneous transluminal angioplasty (PTA) on the
amputation figures for critical leg ischaemia (CLI).
The specific aims of the studies were to assess:
1) The annual incidence of major amputation and amputation trends in the Seinäjoki
Central Hospital region (I)
2) The annual incidence of major amputation and amputation trends in Southern Finland
(II)
3) The impact of infrainguinal reconstructions on major amputation incidence figures in a
population-based analysis during a long study period (II)
4) The relationship between infrapopliteal reconstructions for CLI and major amputation in
a nation-wide analysis of the elderly (≥70 years) population (III)
5) The outcome of infrainguinal PTA for CLI patients in terms of patency, limb salvage
and survival (IV)
6) Changes in diabetes-related and non-diabetes-related vascular lower extremity
amputations in the city of Helsinki (V)
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8. MATERIAL AND METHODS
Study I: A retrospective study was undertaken during the period 1997-2000 at the
Seinäjoki Central Hospital and Ähtäri District Hospital in the Etelä-Pohjanmaa region, with
a catchment area population of about 200 000 (area I). Patients treated in Ähtäri were only
accounted for in the amputation incidence figures, and their records were not reviewed.
The annual number of amputations was recorded. A total of 169 major lower limb
amputations in 156 patients were reviewed. Data relating to the following were analysed:
amputee demographics, diagnosis leading to amputation, vascular status of the limb
before amputation, amputation level and postoperative morbidity, mortality, prosthesis
fitting, ambulation and the state and place of stay of the patient one year after amputation.
The follow-up period was one year.
Study II: In a retrospective survey for the year 2000 covering a catchment area of 1.4
million inhabitants, patient data was gathered from hospital records in the eight surgical
hospitals in Southern Finland (area II). A total of 215 major lower limb amputations in 174
patients were analysed. Data on the following were analysed: demographic factors,
diagnosis, amputation levels, postoperative complications and the state and place of stay
of the patient one year after amputation. The follow-up period was one year. Amputation
data for the period 1984-1995 in the study area was gathered from earlier reports in the
same area, and amputation figures for the period 1990-2001 were also obtained from the
National Research and Development Centre for Welfare and Health (Stakes).
Comparisons with amputation incidence (admissions during which an amputation was
done) between years 1990 to 2000 were made in numbers gathered from Stakes to
reassure similar calculation. The relationship between the incidences of infrainguinal (or
infrapopliteal) bypass and major amputation was analysed for these years. The annual
age-adjusted amputation incidence could be calculated for the period 1990-2001. Although
the year 2000 was the actual end-point in this study, amputation figures for 2001 were also
included to show the trend in figures.
Study III: A nation-wide, retrospective study for the year 1997 was undertaken analysing
data from Stakes on hospital discharges, including demographic, ICD-10 and operative
information on the vascular patients. Elderly patients (≥70 years of age) undergoing
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infrapopliteal bypass surgery or major lower limb amputation for CLI were included in the
study. The 21 Finnish central hospital regions were divided into two groups of equal size
according to their activity in treating patients aged 80 or over using infrapopliteal
reconstructions. Activity was defined by the incidence of infrapopliteal reconstruction
among patients aged 80 or over in each region. The ”active group” (group A) consisted of
11 hospital regions with a total of 83 905 people over 80 years of age living in their area.
The ”passive group” (group B) consisted of 10 hospital regions with a total of 82 305
people aged 80 or over living in their catchment area that year (Table 10). As the study is
nation-wide and each hospital region treats the population living in it’s catchment area, the
two groups should be rather similar with regard to risk factors and confounding factors,
especially as the allocation of the regions to one or other of the groups had no
geographical preponderance. Group A performed 102 infrapopliteal reconstructions on
patients aged 80 or over, while group B performed only 7 distal bypasses on such patients.
The incidence of amputation was calculated and the association between the numbers of
amputations and infrapopliteal reconstructions in the oldest age group was analysed.
Study IV: Data on 221 patients with 230 critically ischaemic limbs treated with consecutive
infrainguinal PTAs at Helsinki University Central Hospital between January 2000 and
December 2002 were collected and analysed retrospectively. Patient data were gathered
from hospital records, the local hospital registry (the HUSVasc Registry) and angiograms.
Survival data were also gathered from the Population Register Center. 
The indication for PTA, pre- and post procedural toe pressures and ankle-brachial (ABI)-
values, demographic data on patients, angiographic data on treated lesions, data on
postprocedular complications and clinical status of the leg as well as the patients after the
PTA were gathered. The mean-follow-up time at the outpatient clinic was 6.7 months
(range 0-40 months). Patients risk factors are shown in Table 11. Patency, limb salvage
and survival rates were calculated on an intention-to-treat basis.
Study V: The clinical records of 1094 patients who underwent major lower limb
amputations for vascular disease in the city of Helsinki during the 13-year period from
1990 to 2002 were analysed retrospectively. Data concerning patient factors, diagnosis,
existence of diabetes and amputation level were recorded. Diabetes was defined
according to WHO. The study period was divided into three periods (1990-1994, 1995-
1998 and 1999-2002) and results were compared between diabetic and nondiabetic
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vascular amputees for these periods. To ensure accurate incidence figures during the
study period, the total number of major amputations in Helsinki was also cross-checked
against figures from the National Research Centre for Welfare and Health (Stakes).
Table 10. Two groups of hospital regions divided according to their activity in performing
distal bypass surgery and amputations for CLI in patients 80 or more years of age.
80 or more years of age
Regions
Total
population
(n)
n Popula-tion (%)
Infra-
popliteal
bypasses
(n)
Ampu-
tations (n)
BK am-
putations (n)
Active regions
A1 795 000 16682 2.1 22 48 27
A2 536 000 19315 3.6 21 38 11
A3 165 000 6472 3.9 4 11 8
A4 207 000 6855 3.3 5 12 2
A5 131 000 4835 3.7 7 6 0
A6 178 000 6081 3.4 4 13 2
A7 167 000 7169 4.3 23 8 1
A8 363 000 9154 2.5 7 29 12
A9 90 000 2458 2.7 5 9 0
A10 71 000 1817 2.6 1 0 0
A11 129 000 3067 2.4 3 7 4
TOTAL 2 832 000 83905 3.3* 102 181 67
Passive regions
P1 257 000 8510 3.3 2 29 11
P2 79 000 2619 3.3 1 5 1
P3 187 000 7032 3.8 1 15 9
P4 259 000 8149 3.1 0 24 7
P5 109 000 4026 3.7 2 18 4
P6 236 000 8770 3.7 1 23 11
P7 69 000 2860 4.1 0 17 9
P8 200 000 7585 3.8 0 29 12
P9 442 000 15613 3.5 0 36 7
P10 444 000 17141 3.9 0 61 11
TOTAL 2 282 000 82305 3.7* 7 257 82
* Median value.
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Table 11. Clinical data and risk factors of 221 patients treated with infra-
inguinal PTA for CLI.
Condition Proportion %
Coronary artery disease 145 / 221 66
Cerebrovascular disease 48 / 221 22
Hypertension 138 / 221 63
Diabetes mellitus 131 / 221 59
Uremia with hemodialysis 27 / 221 12
Any other chronic disease 158 / 221 72
Dyslipidemia with medication 40 / 221 18
BMI > 25 67 / 149* 45*
Current smoking 39 / 201* 19*
* The information was incomplete due to missing data.
Statistical analysis
The statistical analyses were conducted with SPSS (ver 9.0, 11.0, and 12.0.1) statistical
software (SPSS Inc, Chicago, Ill., U.S.A.).
The normality of distributions was established with the Kolmogoroff-Smirnoff goodness-of-
fit test with the Lilliefors method of significance correction. The Independent Samples T-
test was applied for comparisons between two normally distributed groups. When the
distributions were skewed, the Mann-Whitney U-test was applied. (II, V)
Differences between two groups with respect to discrete quantitative variables were tested
with the Mann-Whitney U-test (III). Associations between categorical variables were
analysed with the Chi-Square -test or the Fisher’s Exact -test when appropriate (I, III, V).
Correlations between discrete quantitative variables were assessed by calculating the
Spearman rank correlation coefficient (II, III).
Survival analyses were performed using the Kaplan-Meier method and the Cox regression
model. Primary patency, secondary patency, limb salvage, patients alive with leg and
survival rates were calculated using the Kaplan-Meier method on an intention 
-to-treat basis. Survival data obtained in the Kaplan-Meier analysis were compared using
the log-rank test (univariate analysis). The Cox multiple-regression model was applied to
study differences between groups and to adjust for potential confounding factors. Cox
regression analyses provided estimates of survival probabilities and risk ratios (RR) of
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clinically relevant factors for amputation, end of patency and death. The Wald test was
applied to calculate p-values for data obtained from the Cox multiple regression analysis.
(IV)
Differences between groups were considered statistically significant if the p-values were
less than 0.05 in a two-tailed test (I-V).
60
9. RESULTS
Study I: The annual incidence of major amputations decreased from 295 / million
inhabitants in 1997 to 152 / million inhabitants in 2000. The mean age of the patients was
78.5 years, but highest, at 80.1, in 2000. The reasons for major amputation and their
respective percentages of the total were: CLI with or without diabetes (DM), 79%; acute
ischaemia, 14%; DM with infection and without knowledge of arterial occlusive disease,
3.8%; trauma, 1.3%; frostbite,1.3%. The average below-knee (BK) / above-knee (AK)
amputation ratio was 0.8 during the period 1997-1999 and the ratio was lowest, at 0.67, in
2000. 
The 30-day mortality for all amputees was 10%, and the commonest cause of death was
acute myocardial infarction. After one year, 55% of the patients were alive. Mortality during
the first postoperative year was significantly higher among the AK-amputees than in the
BK-amputated group (Table 12, p= 0.004). At the end of one year, 56.5% of the patients
with unilateral BK-amputation had received a prosthesis and 92% of them could walk with
it. In comparison, only 10.5% of the patients with unilateral AK-amputation had received a
prosthesis and all of these were able to walk with it. One year after amputation the BK-
amputees were able to live at home more often than the AK-amputees (Table 12,
p=0.004).
Table 12. Postoperative place of stay one year after the operation in study areas I
and II.
% of patients
BK AK p-value
Place of stay Area I 34.5 12.3 0.004
Home
Area II 36.1 12.8 0.001
Area I 25.5 20.5 0.53Chronic hospital /
nursing home Area II 8.5 19.6 0.001
Area I 40.0 67.1 0.004
Exitus
Area II 38.9 60.8 0.01
BK = below-knee amputation. AK = above-knee amputation.
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Study II: In 2000, the incidence of major amputations (including reamputations) was 154 /
million inhabitants. At the same time, 135 legs / million inhabitants were lost and 125
patients / million inhabitants underwent amputation. According to data gathered from
STAKES, the incidence of admissions during which an amputation was done was 135 /
million inhabitants (Figure 5). The below-knee (BK) / above-knee (AK) ratio was 0.76
(Figure 6).
The reasons for major amputation in 2000 are shown in Figure 7. Miscellaneous reasons
included burns, rhabdomyolysis, sepsis and cellulitis.
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Fig 5. Annual unadjusted and age-adjusted incidence of admissions with major lower limb
amputation in Southern Finland 1990-2001.
The mean age of the amputees was 72.4. Patients with AK amputation were significantly
older than patients with BK amputations (74.8 versus 69.0, p=0.004). One-week, 30-day
and one-year mortality rates for all amputees were 12%, 29% and 52% respectively.
Mortality during the first postoperative year was significantly higher among the AK-
amputees than in the BK-amputated group (38.9% versus 60.8%, p=0.008, Table 12).
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Fig 6. Below-knee / above-knee ratio in Southern Finland. Figures for the years 1984-1995 have
been published before. Ratio calculated from lost legs.
One year after amputation the BK-amputees were able to live at home (or in a home-like
setting) more often than the AK-amputees (36.1% versus 12.8%, p=0.001). A total of 22%
of all patients and 43% of patients alive at one year received a prosthesis. The patients
who came from home or a home-like setting received a prosthesis more often than chronic
hospital-care patients (42% vs. 2%, p<0.0005). At the end of one year, 68% of patients
with unilateral BK amputation who were alive two months after amputation had received a
prosthesis, compared to only 19% of the corresponding AK-amputated group. Reliable
information on prosthesis usage could not be gathered.
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Fig 7. The causes of amputations in 2000 in Southern Finland.
The absolute decrease in the incidence of major amputations from 1984 to 2000 was 41%.
Compared with the estimation presented by Pohjolainen and colleagues (Pohjolainen
1991) the decrease was 52% (Figure 8). The decrease in amputation incidence from 1990
to 2000 was 25%, and for age-adjusted amputation the decrease inincidence was 30%
(Figure 5). At the same time, the incidence of infrainguinal reconstructions showed an
increase of 755% from 1990 to 2000 (Figure 9). The reduction in the number of
amputations is clearly continuing: the decrease in the age-adjusted amputation incidence
over the period 1990 to 2001 was 44%, and the absolute reduction in incidence from 1984
to 2001 was as high as 52%.
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For the period 1990-2000 there was a significant inverse correlation both between the
incidence of infrainguinal bypass and amputation (r=-0.682, p=0.021) and between the
incidence of infrapopliteal bypass and amputation (r=-0.682, p=0.021).
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Fig 9. Infrainguinal reconstructions and major amputations in Southern Finland 1990-2001.
Study III: The overall major lower limb amputation incidence in Finland for people ≥80
years of age was 2635/million, and was significantly lower in the active region (group A)
than in the passive region (group B) (p=0.016). Similar trends were seen with respect to
BK-amputations and in the 70-74 and 65-79 age groups (Figures 10 and 11). 
Group A performed significantly more distal bypasses on patients aged 80 or over than
group B (p<0.0005). Among patients in this age group there was an inverse correlation
between the incidence of infrapopliteal reconstruction and the incidence of major lower
limb amputation (r= -0.54, p=0.012, Table 13). In addition, there was a difference in the
incidences of below-knee amputations, even though this correlation was not statistically
significant (p=0.106). In the age group 70-74, a significant inverse correlation was found
67
between the incidence of distal bypasses and that of BK-amputations (r= -0.63, p=0.002,
Table 13).
Fig 10. Trend of distal reconstructions and amputations in different age groups.
Table 13. Correlation between the amputation incidence and the  incidence of infrapopliteal
reconstructions for CLI in different age groups.
         Age group
Infrapopliteal
reconstructions and all
amputations
Infrapopliteal reconstructions and
below-knee amputations
Spearman's ρ p Spearman's ρ p
70-74 -0.343 0.118 -0,633** 0.002
75-79 -0.020 0.928 -0.202 0.367
80 and over -0,535* 0.012 -0.363 0.106
*Correlation is significant at the 0.05 level. ** Correlation is significant at the 0.01 level.
68
Fig 11. Trend of distal reconstructions and BK-amputations in different age groups.
Study IV: Some form of complication after PTA was encountered in 16 (7%) legs. The
most common minor complications were groin hematoma, arteriovenous fistula and
thrombosis, all in 3 legs (1,3%). No open surgical procedures were needed for minor
complications as they were managed endovascularly when necessary. The major-
complication rate was 1%: two patients and limbs (1%) suffered a hemorrhage requiring an
emergency operation. The 30-day mortality rate was 4% (n=9). 
Patency
The overall primary patency rate at 12 months was 47% (95% CI 37.1-57.3, Figure 12).
Uremia with hemodialysis, low toe pressure (≤ 30 mmHg) and age under 70 were found, in
a Kaplan-Meier analysis, to be significant risk factors to end patency (Table 14). In the Cox
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regression analysis, however, only low toe pressure (≤ 30 mmHg) was a significant risk
factor to end patency (Table 14).
The secondary patency rate at 12 months was 59% (95% CI 49.3-69.3). 
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Fig. 12. Primary patency of 230 CLI-limbs treated with infrainguinal PTA in HUCH in 2000-2002
(Kaplan-Meier survival curve). SEE = Standard error of estimate.
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Table 14. Kaplan-Meier and Cox regression analysis of factors related to patency
in 230 CLI limbs treated with PTA.
Factor Univariate p-value1
Cox-adjusted
RR (95% CI) Cox p-value
2
Age (< 70 years) 0.0056 1.8 (1.0 - 3.6) NS (0.07)
Gender (male) NS (0.085) 1.3 (0.7 - 2.5) NS (0.47)
DM NS (0.49) 0.8 (0.4 - 1.6) NS (0.6)
Uremia with hemodialysis 0.005 1.5 (0.7 - 3.1) NS (0.25)
Toe pressure (< 30 mmHg) 0.0004 2.6 (1.3 - 5.2) 0.006
Indication (Fontaine IV) NS (0.97) 0.9 (0.4 - 2.0) NS (0.77)
Run off (0) NS (0.25) 1.4 (0.7 - 2.8) NS (0.57)
RR= risk ratio for the end of the patency. NS = non significant
1 Kaplan-Meier analysis; overall patency rates compared with log-rank test.
2 Wald test.
Limb salvage
The overall limb salvage rate was 92% at 12 months (95% CI 88.7-96.1, Figure 13). In a
Kaplan-Meier analysis the significant risk factors for amputation were uremia with
hemodialysis, poor runoff (0-1), low toe pressure (≤ 30 mmHg) and hemodynamic failure
(Table 15). In the Cox regression analysis uremia with hemodialysis, low toe pressure (≤30
mmHg) and hemodynamic failure were found to increase significantly the risk of
amputation (Table 15).
Table 15. Kaplan-Meier and Cox regression analysis of factors related to limb-
salvage in 230 CLI limbs treated with PTA.
Factor Univariate p-value1
Cox-adjusted
RR (95% CI) Cox p-value
2
Age (< 70 years) NS (0.26) 0.6 (0.2 - 1.6) NS (0.29)
Gender (male) NS (0.23) 1.8 (0.6 - 5.5) NS (0.33)
DM NS (0.24) 1.1 (0.3 - 3.4) NS (0.89)
Uremia with hemodialysis 0.0005 4.4 (1.4 - 13.4) 0.009
Indication (Fontaine IV) NS (0.71) 0.7 (0.2 - 2.9) NS (0.6)
Toe pressure (< 30 mmHg) 0.0029 4.8 (1.5 - 15.4) 0.009
Run off (0) 0.006 2.8 (1.0 - 7.5) 0.04
Hemodynamical failure 0.0008 6.0 (2.1 - 17.5) 0.001
RR= risk ratio for major amputation. NS = non significant.
1 Kaplan-Meier analysis; overall limb-salvage rates compared with log-rank test.
2 Wald test.
Survival
The overall cumulative patient survival rates were 76% for one year, 63% for two years
and 46% for three years (Figure 14). Uremia with hemodialysis, coronary artery disease,
tissue loss as indication for PTA (Fontaine stage IV) and age over 70 years were found to
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increase significantly the risk of death both in Kaplan-Meier and in the Cox regression
analysis (Table 16). In the Kaplan-Meier analysis 66% (95%CI 59.6 – 72.6) of the patients
were alive with leg at 12 months.
In recent years there has been a large overall increase in endovascular procedures,
including infra-inguinal PTAs, at HUCH (Figure 15).
Over the period 1991-2000 there was a significant inverse correlation both between the
number of infrainguinal PTA procedures and amputation (r=-0.842, p=0.002) and between
the number of infrapopliteal PTA procedures and amputation (r=-0.636, p=0.048).
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Fig. 13. Limb salvage of 230 CLI-limbs treated with infrainguinal PTA in HUCH in 2000-2002
(Kaplan-Meier survival curve). SEE = Standard error of estimate.
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Survival
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Fig. 14. Survival of 221 CLI-patients treated with infrainguinal PTA in HUCH in 2000-2002 (Kaplan-
Meier survival curve). SEE = Standard error of estimate.
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Table 16. Kaplan-Meier and Cox regression analysis of factors related to survival
in 221 patients with CLI treated with PTA.
Factor Univariate p-value1
Cox-adjusted RR
(95% CI) Cox p-value
2
Age (> 70 years) 0.0005 2.9 (1.7 - 4.8) <0.0001
Gender (male) NS (0.25) 0.9 (0.6 - 1.5) NS (0.9)
DM NS (0.18) 1.2 (0.7 - 1.8) NS (0.5)
Uremia with hemodialysis 0.02 2.3 (1.3 - 4.2) 0.006
Coronary artery disease 0.01 1.7 (1.0 - 2.7) 0.032
Cerebrovascular disease NS (0.07) 1.4 (0.8 - 2.2) NS (0.21)
Indication (Fontaine IV) 0.003 3.2 (1.4 - 7.6) <0.0001
Amputation after PTA NS (0.33) 0.6 (0.3 - 1.4) NS (0.23)
RR= risk ratio for major amputation. NS = non significant.
1 Kaplan-Meier analysis; overall limb-salvage rates compared with log-rank test.
2 Wald test.
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Study V: From 1990 through 2002, 561 of the total of 1094 patients who underwent major
lower limb amputation had diabetes mellitus. Of these, 283 (50,4%) were men. The overall
mean age of the diabetics was 72 (range 29-102), significantly lower than that of the non-
diabetics (76, range 32-100, p<0.001, Table 17). Male diabetics were younger than the
female, the mean ages being 68 (range 31-97) and 76 (29-102) respectively (p<0.001).
Among younger diabetic amputees (under 60 years) 74% were male, while 46% of
diabetic amputees aged 60 or over were male (p<0.001). 
The BK/AK-ratio was significantly lower among nondiabetics (Table 17). The proportion of
BK- and AK-amputations among diabetics and nondiabetics over the three time periods
are shown in Table 18. Among diabetic amputees aged under 60, 74% had BK-
amputation, while 55% of diabetics aged 60 or over had BK-amputation during the study
period (Table 18).
Table 17. Comparison of diabetic and nondiabetic vascular amputees.
DM non-DM p
Age (mean, range) 72.1 (29 - 102) 76.3 (32 - 100) < 0.001
Gender (% of females, n) 50% (278/561) 56% (297/533) NS(0.046)
BK/AK -ratio (n) 1.4 (323/238) 0.6 (198/335) < 0.001
Table 18. Major amputation rates for diabetic and nondiabetic leg ischaemia.
BK / AK -ratio (n)
1990-1994 1995-1998 1999-2002 p-value
Diabetics 1.7 (129 / 74) 1.4 (102 / 73) 1.0 (92 / 91) 0.03
Nondiabetics 0.6 (65 / 114) 0.7 (75 / 113) 0.5 (58 / 108) NS (0.6)
Diabetics < 60 years of age 5.2 (26 / 5) 2.7 (19 / 7) 1.8 (20 / 11) NS (0.22)
Nondiabetics < 60 years of age 1.4 (10 / 7) 1.6 (13 / 8) 3.3 (13 / 4) NS (0.51)
Diabetics > 60 years of age 1.5 (103 / 69) 1.3 (83 / 66) 0.9 (72 / 80) NS (0.07)
Nondiabetics > 60 years of age 0.5 (55 / 107) 0.6 (62 / 105) 0.4 (45 / 104) NS (0.43)
The overall incidence of major amputations in diabetics decreased from the first period to
the last by 23% (Table 19). At the same time, the incidence of major amputations for
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vascular disease among non-diabetics decreased from the first period to the last by 40%.
By taking into account the prevalence of diabetes  in 1990 and 2000 in Finland, diabetes-
specific incidence rates could be calculated. According to these calculations, a 33 % fall in
major amputations per million individuals with diabetes was observed during the study
period.
Table 19. Major amputation rates for diabetic and nondiabetic leg ischaemia.
Time period
1990-1994 1995-1998 1999-2002 p-value
Amputation incidence (DM)* 94.6 84.5 73.2
Amputation incidence (non-DM)* 89.0 70.7 53.4
DM in patients < 60 years of age 31 / 48 (65%) 26 / 47 (55%) 31 / 48 (65%) NS (0.56)
DM in patients > 60 years of age 172 / 334 (52%) 149 / 316 (47%) 152 / 301 (51%) NS (0.52)
*Mean annual amputation incidence/1 000 000 inhabitants
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10 DISCUSSION
10.1 Limitations of the study
Certain limiting factors and selection bias are inherent in most clinical studies, and this is
true of our studies too:
Study I:
The first study could be regarded as a survey, as only trends of amputation and amputees
were described and the reason for the decrease in amputation incidence was not truly
analysed.
Studies II & III:
In these two population-based analyses the incidence of amputation and infrainguinal or
infrapopliteal bypass surgery were gathered from the National Research and Development
Centre for Welfare and Health (Stakes). These data were collected in a uniform manner
from all hospital regions, and systematic errors are therefore unlikely to skew results
markedly. Accuracy of registration of data can vary between hospitals and hospital regions
in registers operating on a voluntary basis, such as the Finnvasc-registry (Kantonen et al.
1997). In study III the pooling of data from many hospital regions should also eliminate the
possibility of local factors skewing results. In study III, despite collection from a nation-wide
register, the numbers of elderly patients undergoing surgery in one year were relatively
small, resulting only in trends and not statistically significant differences in some groups. 
Study IV:
This study was conducted at an academic referral centre, which may cause some
selection bias. The fact that, at this centre, PTA in the treatment of CLI has so far been
preferred for only short occlusions and stenotic lesions or in cases when surgery is not
possible means that this study population is not comparable with the CLI patients who are
operatively managed at the same centre.
Study V:
Patient data for a rather long period of time could be gathered only in the city of Helsinki.
To ensure accurate incidence figures during the study period, total major amputation
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figures in Helsinki were also cross-checked against those from the National Research
Centre for Welfare and Health (Stakes). There was some discrepancy between the data
gathered from Stakes and that from the hospital records. Average incidence numbers were
estimated on the basis of these two information sources. 
10.2 General discussion
Currently, there is an ongoing controversy as to whether there has been a significant
reduction in amputations as a result of increasing revascularisation procedures in patients
with CLI. Institutional reports have shown excellent clinical patient outcome after arterial
reconstruction as well as angioplasty, but may be misleading in the evaluation of the
impact of treatment in the population, as the analysis is skewed by selection bias in
referral centres (Luther et al. 1996). There are, however, some studies which demonstrate
the efficacy of revascularisation as a decrease in amputation rates at the populational level
(Ebskov et al. 1994; Eickhoff 1993; Gutteridge et al. 1994; Hallett et al. 1997; Karlstrom
and Bergqvist 1997; Luther 1994). We conducted two population-based studies (II, III) to
clarify the association between reconstructions and amputation. In study II we analysed a
population living in a defined area during a rather long period of time, thus, this study gives
long-term amputation data in an era of evolving vascular surgery for limb salvage. In study
III, data were collected nation-wide for one year. On the basis of our results, we conclude
that an increase in vascular infrainguinal reconstructions reduces the number of major
lower limb amputations. 
The population in most western countries is growing older, with a marked increase in the
group of octogenarians and older. The incidence of chronic critical ischaemia shows an
increase with increasing age (Dormandy et al. 1999e; Murabito et al. 1997; Reunanen et
al. 1982). Several studies have shown a steep increase in amputation rates with
increasing age (Group TG 2000; Liedberg and Persson 1983; Luther 1994; Pohjolainen
and Alaranta 1988). There are also a number of studies showing that the mobility of the
patient is severely restricted by amputation, as few of the elderly amputees can be
rehabilitated to walking with a prosthesis (Houghton et al. 1992; McWhinnie et al. 1994;
Pohjolainen et al. 1990). This results in high costs to the community, as a large proportion
of these patients with restricted ambulation become dependent on care in institutions
(Luther 1997). Several authors propose an active reconstruction policy in elderly patients
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(Esato et al. 1993; Gouny et al. 1994; Illuminati et al. 2000; Illuminati et al. 1999; Luther
and Lepantalo 1997a; Luther and Lepantalo 1997b; Matsubara et al. 2001; McLoughlin et
al. 1989; Nehler et al. 1993; O'Mara et al. 1987; Pomposelli et al. 1998; Scher et al. 1986),
provided that a successful bypass procedure is likely to improve the quality of life of these
patients by maintaining ambulatory function and independent living (Luther 1997).
Yet again, to evaluate the effectiveness of arterial reconstructive treatment in CLI it is
essential to evaluate its impact on amputation rates in the population (Luther et al. 1996).
With an increasing proportion of patients with critical ischaemia aged 80 or over, it is
important to determine if results in this age group justify an active reconstruction policy. On
the basis of the results of our study III, it is clear that an active approach to distal bypass is
associated with a reduced requirement for amputation in this age group especially. Age
alone should not be a deterrent to revascularisation for limb salvage.
A nationwide study in Finland showed an inverse correlation between the incidence of
infrapopliteal surgical reconstructions and that of below-knee amputations (Luther et al.
2000). Our study group found a similar inverse correlation for the elderly Finnish
population (III). In addition, it was found in studies I, II and V that, as the overall incidence
of major amputations decreased during the study period, the proportion of AK-amputations
rose (BK/AK-ratio decreased). A similar finding was reported in a population-based study
in Varberg, Sweden (Karlstrom and Bergqvist 1997) and in Copenhagen, Denmark
(Pedersen et al. 1994). Thus, it is apparent that the number of BK-amputations could be
altered by infrapopliteal revascularisation and the relative number of AK-amputations
inevitably rises. The real index of success in vascular surgery is the proportion of patients
who regain mobility with a preserved limb. The BK/AK-ratio is not a proper measure of
that. Thus, focusing solely on the BK/AK-ratio without taking into consideration the total
incidence of amputation misinterprets the picture.
The current 1-year mortality rates of the patients who underwent amputation in the areas
studied were high: 45% (I) and 52% (II), respectively. In Southern Finland, the one-year
mortality has increased significantly since the 1990s (Alaranta et al. 1995, Laaperi et al.
1993, Pohjolainen and Alaranta 1999). This is due to the current aggressive approach of
treating even old, fragile and multidiseased patients with reconstructions (II). This is also
indicated by the low overall amputation rate as compared to other amputation series
(Ebskov et al. 1994; Gutteridge et al. 1994; Karlstrom and Bergqvist 1997; Lindholt et al.
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1994; Luther et al. 2000; Rommers et al. 1997; TASC 2000) as well as previous reports
from Southern Finland (Alaranta et al. 1995; Laaperi et al. 1993; Pohjolainen and Alaranta
1988; Pohjolainen and Alaranta 1999). Other manifestations of arterial occlusive disease,
mainly cardio- and cerebrovascular diseases, explain high mortality (Dormandy et al.
1999b; Luther 2003). 
It is interesting that in the series of PTA-studies on CLI-patients, many studies report high
limb salvage and clinical improvement rates (72-89% in 2-3 years), regardless of the
generally low patency rates (Boyer et al. 2000; Lofberg et al. 1996; London et al. 1995). In
our study (IV) the hemodynamic patency rate was also considerably low, whereas the limb
salvage rate was extremely high. This indicates that in some cases the initial success of
infra-inguinal PTA could be sufficient for a favourable outcome in patients with CLI. Or,
one might doubt, whether all these treated patients had true CLI and what would have
been the limb loss rate if these same patients had undergone no intervention other than
the best medical therapy. So far, in Helsinki, the CLI patients treated with PTA have had
shorter lesions than those treated with a bypass operation. The results of study IV support
the view that PTA could be considered as a first-line treatment in a selected group of CLI-
patients. However, there is clearly a need for a randomized prospective study to determine
the optimal primary intervention for different kind of lesions and patients. 
The implementation of a multidisciplinary team approach for the prevention and treatment
of diabetic foot ulcers has been reported to be an effective means of preventing
amputations in the diabetic patient (Edmonds et al. 1986; Gibbons et al. 1993; Holstein et
al. 2000; Larsson et al. 1995; Morris et al. 1998; van Houtum et al. 2004). However, it is
difficult or impossible to give a direct answer to the question of what caused the decrease
in the amputation rate in diabetics and to what extent in the study areas; what is the exact
role of vascular surgery as a part of multidisciplinary team in decreasing amputation
figures. As at the same time increase in vascular surgical activity has happened
throughout the world. 
The incidence of major amputations in diabetic patients in Helsinki has decreased by 23%
from the beginning of the 1990s (1990-1994) to the beginning of this millenium (1999-
2002) (V). By taking into account the prevalence of diabetes in 1990 and 2000 in Finland,
the diabetes-specific incidence rates could be calculated for the study area. This gave a 
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33 % fall in major amputations per million individuals with diabetes during the study period.
HUCH implements an aggressive policy of attempting revascularisation in all patients with
CLI who have the possibility of maintaining independence with the preserved limb,
presuming that the limb is salvageable and the patient´s condition allows surgical or
radiological procedures. Diabetes alone never deters aggressive attempts at limb salvage. 
On the basis of our results, we conclude, as do several others, that an increase in vascular
reconstructions also reduces the number of major lower limb amputations in diabetic
patients. The establishment of a diabetic foot team and better treatment of diabetic foot
ulcers also have an important role in the prevention of amputations. Thus, this study
cannot give a direct answer on the impact of vascular surgery or the work of a
multidisciplinary diabetic foot team on the amputation figures; however both seem to
improve results. 
Finally, to ascertain the appropriate treatment methods for CLI, large, properly designed
prospective randomised studies need to be performed in the near future.
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11. CONCLUSIONS
1. The incidence of major amputation has decreased in the hospital region without a
university hospital (Seinäjoki Central Hospital region) during recent years. 
2. The incidence of major amputation has decreased in the hospital region with a
university hospital (Southern Finland). The diminishing group of patients undergoing
major amputation are often multimorbid. The proportion of AK-amputations has
increased, mortality of the amputees is high and rehabilitation possibilities are low. 
3. Infrapopliteal bypass can be considered as an index-procedure in preventing major
amputations.
4. A decrease in amputation rates among elderly patients can be achieved by means of
active revascularisation at least as well as in younger patients. 
5. PTA can be considered as a first-line treatment in a selected group of CLI-patients, as
it gives good limb salvage rates. However, there is clearly a need for a randomised
prospective study to determine the optimal primary intervention for different kinds of
lesions and patients, now in the gray area of uncertainty. 
6. The decrease in major amputation rates among diabetic as well as nondiabetic patients
can be attributed to the increased interest in amputation prevention. 
83
12. ACKNOWLEDGEMENTS
I wish to express my gratitude and appreciation to:
My supervisor, professor Mauri Lepäntalo, for introducing me to the interesting field of
vascular research. Without Mauri´s continous support, clear instructions and extensive
knowledge of vascular surgery, this study would not have been possible. Mauri has always
found time to teach and give advice. Besides carrying out scientific work, Mauri also sets
an example as a talented surgeon and chief, who takes and gives responsibility wisely. It
has been a privilege to work as a vascular trainee at his clinic for these past three years.
Antti Eskelinen, M.D., my beloved husband and respected co-worker, for his tireless help
with the statistical analyses and all details relating to the computer programmes. I am
indebted to him for unselfishly putting so much time and effort into my study. Antti´s ever
lasting optimism, faith in me and love were the cornerstones of this work.
Mikael Luther, M.D., for sharing with me his research material for the third part of this
study. I appreciate him for teaching me scientific writing and giving valuable advice, which
has helped me in preparing subsequent manuscripts too.
Anders Albäck, M.D., who put his knowledge of vascular research at my disposal. I am
grateful to him for astute comments, revisions in writing and many fruitful discussions.
Ari Jaakkola, M.D., for the idea of a survey of amputations, and Timo Hyytinen, M.D., for
the idea of the questionnares to the amputees in Seinäjoki Central Hospital. I am thankful
to both these skillful vascular suregons for their help and engouragement at the beginning
of the study.
Docent Kimmo Mäkinen and Docent Timo Pohjolainen, who gave me very valuable advice,
constructive criticism and encouraging support. I am deeply grateful to them for an
improved manuscript.
84
My co-authors: Eeva-Maija Weselius, M.D., Mikael Railo,M.D., Henrik Sell, M.D., Docent
Leena Kauppila, Docent Erkki Tukiainen, Ilkka Mäenpää, M.D., Juha Pitkänen, M.D., Päivi
Salminen-Peltola, M.D., Suvi Leutola, M.D, Docent Aarne Kivioja, Asko Lukinmaa, M.D.,
Peter Brasken ,M.D., Wolf-Dieter Roth, M.D., Kimmo Lappalainen, M.D. and Pekka Keto,
M.D., for their advice and contribution to my work.
Wolf-Dieter Roth, M.D., for expert advice on the radiological aspects of the fourth part of
the study, and Sorjo Mätzke, M.D., for her kind help in all kinds of practical matters.
Anita Mäkelä, R.N. and Leena Sipilä, R.N., for help with data collection in the second part
of this work and help with many practical things, and Mrs Leena Multanen, for help with
many practical things.
Other colleagues and teachers: Pekka Aho, M.D., Marianne Jaroma, M.D., Milla Kallio,
M.D., Ilkka Kantonen, M.D., Petteri Kauhanen, M.D., Juhani Kellosalo, M.D., Sani
Laukontaus, M.D., Katariina Laurila, M.D., Aarno Lehtola, M.D., Maria Söderström, M.D.,
Pirkka Vikatmaa, M.D., Sailaritta Vuorisalo, M.D. and many others for their help and
support.
Mr Barry White, for prompt and expert revision of the English text.
The nurses and staff of the Seinäjoki Central Hospital and the Meilahti hospital.
My parents Maija-Liisa and Jouko Pihlaja, for providing a loving and supportive home, and
Marika Pihlaja, D.D.S., my dear sister, for guiding me during the first years in medical
school and for her faithfull friendship and support.
Finally, Antti and our Aarne, for being the love and light of my life.
Karin and Einar Stroems Foundation, Instrumentarium Research Foundation, Orion
Research Foundation, Pehr Oscar Klingendahl´s Foundation, Etelä-Pohjanmaan
Lääkäriseura, Biomedicum Helsinki Foundation, Clinical Research Institute HUCH Ltd.,
The Finnish Medical Foundation, sanofi-aventis / Bristol-Myers Squibb, for financial
support.
85
13. REFERENCES
Abou-Zamzam, A.M., Jr., Teruya, T.H., Killeen, J.D. and Ballard, J.L. Major lower extremity
amputation in an academic vascular center. Ann Vasc Surg. 2003; 17: 86-90.
Ad Hoc Committee. Suggested standards for reports dealing with lower extremity
ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for
Vascular Surgery/North American Chapter, International Society for Cardiovascular
Surgery. J Vasc Surg. 1986; 4: 80-94.
AhChong, A.K., Chiu, K.M., Wong, M.W., Hui, H.K. and Yip, A.W. Diabetes and the
outcome of infrainguinal bypass for critical limb ischaemia. ANZ J Surg. 2004; 74:
129-33.
Akbari, C.M., Pomposelli, F.B., Jr., Gibbons, G.W., Campbell, D.R., Pulling, M.C., Mydlarz,
D. and LoGerfo, F.W. Lower extremity revascularization in diabetes: late
observations. Arch Surg. 2000; 135: 452-6.
Alaranta, H., Alaranta, R., Pohjolainen, T. and Karkkainen, M. Lower limb amputees in
Southern Finland. Prosthet Orthot Int. 1995; 19: 155-8.
Albers, M., Fratezi, A.C. and De Luccia, N. Assessment of quality of life of patients with
severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg.
1992; 16: 54-9.
Aronow, W.S. and Ahn, C. Prevalence of coexistence of coronary artery disease,
peripheral arterial disease, and atherothrombotic brain infarction in men and women
> or = 62 years of age. Am J Cardiol. 1994; 74: 64-5.
Aulivola, B., Hile, C.N., Hamdan, A.D., Sheahan, M.G., Veraldi, J.R., Skillman, J.J.,
Campbell, D.R., Scovell, S.D., LoGerfo, F.W. and Pomposelli, F.B., Jr. Major lower
extremity amputation: outcome of a modern series. Arch Surg. 2004; 139: 395-9;
discussion 399.
Benotmane, A., Mohammedi, F., Ayad, F., Kadi, K. and Azzouz, A. Diabetic foot lesions:
etiologic and prognostic factors. Diabetes Metab. 2000; 26: 113-7.
Biancari, F., Alback, A., Kantonen, I., Luther, M. and Lepantalo, M. Predictive factors for
adverse outcome of pedal bypasses. Eur J Vasc Endovasc Surg. 1999; 18: 138-43.
Biancari, F., Kantonen, I., Alback, A., Matzke, S., Luther, M. and Lepantalo, M. Limits of
infrapopliteal bypass surgery for critical leg ischemia: when not to reconstruct.
World J Surg. 2000; 24: 727-33.
Biancari, F., Kantonen, I., Matzke, S., Alback, A., Roth, W.D., Edgren, J. and Lepantalo,
M. Infrainguinal endovascular and bypass surgery for critical leg ischemia in
patients on long-term dialysis. Ann Vasc Surg. 2002; 16: 210-4.
Bloor, K. Natural history of arteriosclerosis of the lower extremities. Ann Roy Coll Surg
Engl. 1961; 28: 36-52.
Bohm, G. and Al-Khaffaf, H. Thrombophilia and arterial disease. An up-to-date review of
the literature for the vascular surgeon. Int Angiol. 2003; 22: 116-24.
Bolia, A., Brennan, J. and Bell, P.R. Recanalisation of femoro-popliteal occlusions:
improving success rate by subintimal recanalisation. Clin Radiol. 1989; 40: 325.
Bolia, A., Miles, K.A., Brennan, J. and Bell, P.R. Percutaneous transluminal angioplasty of
occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc
Intervent Radiol. 1990; 13: 357-63.
Boyer, L., Therre, T., Garcier, J.M., Perez, N., Ravel, A., Privat, C. and Viallet, J.F.
Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol.
2000; 41: 73-7.
86
Bradbury, A. Angioplasty is the first-line treatment for critical limb ischaemia, Against the
motion, Charing Cross, London, UK, 2003.
Bradbury, A.W., Bell, J., Lee, A.J., Prescott, R.J., Gillespie, I., Stansby, G. and Fowkes,
F.G. Bypass or angioplasty for severe limb ischaemia? A Delphi Consensus Study.
Eur J Vasc Endovasc Surg. 2002; 24: 411-6.
Bradbury, A.W. and Ruckley, C.V. Angioplasty for lower-limb ischaemia: time for
randomised controlled trials. Lancet. 1996; 347: 277-8.
Burgess, E.M. and Matsen, F.A., 3rd. Determining amputation levels in peripheral vascular
disease. J Bone Joint Surg Am. 1981; 63: 1493-7.
Burns, P.J., Mosquera, D.A. and Bradbury, A.W. Prevalence and significance of
thrombophilia in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2001; 22:
98-106.
Campbell, W.B., St Johnston, J.A., Kernick, V.F. and Rutter, E.A. Lower limb amputation:
striking the balance. Ann R Coll Surg Engl. 1994; 76: 205-9.
CAPRIE Steering group. A randomised, blinded, trial of clopidogrel versus aspirin in
patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet. 1996; 348: 1329-39.
Catalano, M. Epidemiology of critical limb ischaemia: North Italian data. Eur J Med. 1993;
2: 11-4.
Christensen, K.S. and Klarke, M. Transcutaneous oxygen measurement in peripheral
occlusive disease. An indicator of wound healing in leg amputation. J Bone Joint
Surg Br. 1986; 68: 423-6.
Cooper, L.T., Tse, T.S., Mikhail, M.A., McBane, R.D., Stanson, A.W. and Ballman, K.V.
Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's
disease). J Am Coll Cardiol. 2004; 44: 2410-1.
Criqui, M.H. Peripheral arterial disease--epidemiological aspects. Vasc Med. 2001; 6: 3-7.
Criqui, M.H., Fronek, A., Barrett-Connor, E., Klauber, M.R., Gabriel, S. and Goodman, D.
The prevalence of peripheral arterial disease in a defined population. Circulation.
1985; 71: 510-5.
Cruz, C.P., Eidt, J.F., Capps, C., Kirtley, L. and Moursi, M.M. Major lower extremity
amputations at a Veterans Affairs hospital. Am J Surg. 2003; 186: 449-54.
Czerny, M., Trubel, W., Zimpfer, D., Grimm, M., Koller, R., Hofmann, W., Holzenbein, T.,
Polterauer, P. and Girsch, W. Limb-salvage by femoro-distal bypass and free
muscle flap transfer. Eur J Vasc Endovasc Surg. 2004; 27: 635-9.
Da Silva, A., Widmer, L.K., Ziegler, H.W., Nissen, C. and Schweizer, W. The Basle
longitudinal study: report on the relation of initial glucose level to baseline ECG
abnormalities, peripheral artery disease, and subsequent mortality. J Chronic Dis.
1979; 32: 797-803.
Da Silva, A.F., Desgranges, P., Holdsworth, J., Harris, P.L., McCollum, P., Jones, S.M.,
Beard, J. and Callam, M. The management and outcome of critical limb ischaemia
in diabetic patients: results of a national survey. Audit Committee of the Vascular
Surgical Society of Great Britain and Ireland. Diabet Med. 1996; 13: 726-8.
Dionyssiou-Asteriou, A., Papastamatiou, M., Vatalas, I. and Bastounis, E. Serum Lp(a)
lipoprotein levels in patients with atherosclerotic occlusive disease of the lower
extremities. Eur J Vasc Endovasc Surg. 2000; 20: 57-60.
Donnelly, R. and Yeung, J.M. Management of intermittent claudication: the importance of
secondary prevention. Eur J Vasc Endovasc Surg. 2002; 23: 100-7.
87
Dormandy, J., Heeck, L. and Vig, S. Acute limb ischemia. Semin Vasc Surg. 1999a; 12:
148-53.
Dormandy, J., Heeck, L. and Vig, S. The fate of patients with critical leg ischemia. Semin
Vasc Surg. 1999b; 12: 142-7.
Dormandy, J., Heeck, L. and Vig, S. Major amputations: clinical patterns and predictors.
Semin Vasc Surg. 1999c; 12: 154-61.
Dormandy, J., Heeck, L. and Vig, S. The natural history of claudication: risk to life and
limb. Semin Vasc Surg. 1999d; 12: 123-37.
Dormandy, J., Heeck, L. and Vig, S. Predicting which patients will develop chronic critical
leg ischemia. Semin Vasc Surg. 1999e; 12: 138-41.
Dorros, G., Jaff, M.R., Dorros, A.M., Mathiak, L.M. and He, T. Tibioperoneal (outflow
lesion) angioplasty can be used as primary treatment in 235 patients with critical
limb ischemia: five-year follow-up. Circulation. 2001; 104: 2057-62.
Dotter, C.T. and Judkins, M.P. Transluminal Treatment of Arteriosclerotic Obstruction.
Description of a New Technic and a Preliminary Report of Its Application.
Circulation. 1964; 30: 654-70.
Doubilet, P. and Abrams, H.L. The cost of underutilization. Percutaneous transluminal
angioplasty for peripheral vascular disease. N Engl J Med. 1984; 310: 95-102.
Ebskov, L.B. Level of lower limb amputation in relation to etiology: an epidemiological
study. Prosthet Orthot Int. 1992; 16: 163-7.
Ebskov, L.B. Major amputation for malignant melanoma: an epidemiological study. J Surg
Oncol. 1993; 52: 89-91.
Ebskov, L.B. Trauma-related major lower limb amputations: an epidemiologic study. J
Trauma. 1994; 36: 778-83.
Ebskov, L.B., Schroeder, T.V. and Holstein, P.E. Epidemiology of leg amputation: the
influence of vascular surgery. Br J Surg. 1994; 81: 1600-3.
Edmonds, M.E., Blundell, M.P., Morris, M.E., Thomas, E.M., Cotton, L.T. and Watkins, P.J.
Improved survival of the diabetic foot: the role of a specialized foot clinic. Q J Med.
1986; 60: 763-71.
Eickhoff, J.H. Changes in the number of lower limb amputations during a period of
increasing vascular surgical activity. Results of a nation-wide study, Denmark,
1977-1990. Eur J Surg. 1993; 159: 469-73.
Esato, K., Zempo, N., M, O.h., Fujioka, K. and Kuga, T. Arterial reconstruction in elderly
patients. Cardiovasc Surg. 1993; 1: 228-31.
Estes, J.M. and Pomposelli, F.B., Jr. Lower extremity arterial reconstruction in patients
with diabetes mellitus. Diabet Med. 1996; 13 Suppl 1: S43-7.
European Consensus Document on CLI. European consensus document on Critical Leg
Ischaemia. March 1989., Springer-Verlag, Berlin, 1990.
Faglia, E., Favales, F., Quarantiello, A., Calia, P., Clelia, P., Brambilla, G., Rampoldi, A.
and Morabito, A. Angiographic evaluation of peripheral arterial occlusive disease
and its role as a prognostic determinant for major amputation in diabetic subjects
with foot ulcers. Diabetes Care. 1998; 21: 625-30.
Faglia, E., Mantero, M., Caminiti, M., Caravaggi, C., De Giglio, R., Pritelli, C., Clerici, G.,
Fratino, P., De Cata, P., Dalla Paola, L., Mariani, G., Poli, M., Settembrini, P.G.,
Sciangula, L., Morabito, A. and Graziani, L. Extensive use of peripheral angioplasty,
particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical
results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med.
2002; 252: 225-32.
88
Feinglass, J., Brown, J.L., LoSasso, A., Sohn, M.W., Manheim, L.M., Shah, S.J. and
Pearce, W.H. Rates of lower-extremity amputation and arterial reconstruction in the
United States, 1979 to 1996. Am J Public Health. 1999; 89: 1222-7.
Fogarty, T.J., Cranley, J.J., Krause, R.J., Strasser, E.S. and Hafner, C.D. A method for
extraction of arterial emboli and thrombi. Surg Gynecol Obstet. 1963; 116: 241-4.
Fontaine, R., KIm, M. and Kieny, R. Die chirurgische behandlungen der peripheren
durchblutungsstörungen. Helv Chir Acta. 1955; 36: 499-533.
Fowkes, F.G., Housley, E., Riemersma, R.A., Macintyre, C.C., Cawood, E.H., Prescott,
R.J. and Ruckley, C.V. Smoking, lipids, glucose intolerance, and blood pressure as
risk factors for peripheral atherosclerosis compared with ischemic heart disease in
the Edinburgh Artery Study. Am J Epidemiol. 1992; 135: 331-40.
Gibbons, G.W. The diabetic foot: amputations and drainage of infection. J Vasc Surg.
1987; 5: 791-3.
Gibbons, G.W. and Eiopoulos, G.M. Infection of the diabetic foot, Saunders, Philadelphia,
1995.
Gibbons, G.W., Marcaccio, E.J., Jr., Burgess, A.M., Pomposelli, F.B., Jr., Freeman, D.V.,
Campbell, D.R., Miller, A. and LoGerfo, F.W. Improved quality of diabetic foot care,
1984 vs 1990. Reduced length of stay and costs, insufficient reimbursement. Arch
Surg. 1993; 128: 576-81.
Gouny, P., Bertrand, P., Decaix, B., Hocquet-Cheynel, C., Karcenty, B., Chemla, M. and
Nussaume, O. Distal bypass for limb salvage: comparative study in patients below
and above 80 years of age. J Cardiovasc Surg (Torino). 1994; 35: 419-24.
Grimer, R.J., Taminiau, A.M. and Cannon, S.R. Surgical outcomes in osteosarcoma. J
Bone Joint Surg Br. 2002; 84: 395-400.
Group TG. Epidemiology of lower extremity amputation in centres in Europe, North
America and East Asia. The global lower extremity amputation study group. Br J
Surg. 2000; 87: 328-37.
Gutteridge, B., Torrie, P. and Galland, B. Trends in arterial reconstruction, angioplasty and
amputation. Health Trends. 1994; 26: 88-91.
Hallett, J.W., Jr., Byrne, J., Gayari, M.M., Ilstrup, D.M., Jacobsen, S.J. and Gray, D.T.
Impact of arterial surgery and balloon angioplasty on amputation: a population-
based study of 1155 procedures between 1973 and 1992. J Vasc Surg. 1997; 25:
29-38.
Harrington, E.B., Harrington, M.E., Schanzer, H. and Haimov, M. End-stage renal disease-
-is infrainguinal limb revascularization justified? J Vasc Surg. 1990; 12: 691-5;
discussion 695-6.
Harris, P.L., Veith, F.J., Shanik, G.D., Nott, D., Wengerter, K.R. and Moore, D.J.
Prospective randomized comparison of in situ and reversed infrapopliteal vein
grafts. Br J Surg. 1993; 80: 173-6.
Hearn, A.T., Smith, J.M., Welling, R.E., Lohr, J.M. and Thibodeaux, L.C. Analysis of
autogenous vein femoral-infrapopliteal bypass for limb salvage in the elderly.
Cardiovasc Surg. 1996; 4: 105-9.
Heikkinen, M., The Vascular Surgical Service - Review of the 1990s and Future Prospects,
Tampere University, Tampere, 2003.
Heikkinen, M.A., Salenius, J.P., Saarinen, J.P., Laurikka, J., Metsanoja, R., Zeitlin, R.,
Suominen, V. and Auvinen, O. Regional differences in the use of a vascular surgical
service and incidence of amputations in a well-defined geographical area. Eur J
Surg. 2002; 168: 724-9.
89
Holdsworth, J. District hospital management and outcome of critical lower limb ischaemia:
comparison with national figures. Eur J Vasc Endovasc Surg. 1997; 13: 159-63.
Holm, J., Arfvidsson, B., Jivegard, L., Lundgren, F., Lundholm, K., Schersten, T.,
Stenberg, B., Tylen, U., Zachrisson, B.F., Lindberg, H. and et al. Chronic lower limb
ischaemia. A prospective randomised controlled study comparing the 1-year results 
of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc
Surg. 1991; 5: 517-22.
Holstein, P., Ellitsgaard, N., Olsen, B.B. and Ellitsgaard, V. Decreasing incidence of major
amputations in people with diabetes. Diabetologia. 2000; 43: 844-7.
Houghton, A.D., Taylor, P.R., Thurlow, S., Rootes, E. and McColl, I. Success rates for
rehabilitation of vascular amputees: implications for preoperative assessment and
amputation level. Br J Surg. 1992; 79: 753-5.
Humphreys, W.V., Evans, F., Watkin, G. and Williams, T. Critical limb ischaemia in
patients over 80 years of age: options in a district general hospital. Br J Surg. 1995;
82: 1361-3.
ICAI. Long-term mortality and its predictors in patients with critical leg ischaemia. The
I.C.A.I. Group (Gruppo di Studio dell'Ischemia Cronica Critica degli Arti Inferiori).
The Study Group of Criticial Chronic Ischemia of the Lower Exremities. Eur J Vasc
Endovasc Surg. 1997; 14: 91-5.
Illuminati, G., Bertagni, A., Calio, F.G. and Papaspyropoulos, V. Distal
polytetrafluoroethylene bypasses in patients older than 75 years. Arch Surg. 2000;
135: 780-4.
Illuminati, G., Calio, F.G., Bertagni, A., Piermattei, A., Vietri, F. and Martinelli, V. Results of
distal revascularization in elderly patients for critical ischemia of the lower limbs.
Acta Chir Belg. 1999; 99: 68-71.
International Consensus on the Diabetic Foot. International Consensus on the Diabetic
Foot, Amsterdam, 1999.
Jamsen, T., Manninen, H., Tulla, H. and Matsi, P. The final outcome of primary
infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with
chronic critical limb ischemia. J Vasc Interv Radiol. 2002; 13: 455-63.
Jivegard, L.E., Augustinsson, L.E., Holm, J., Risberg, B. and Ortenwall, P. Effects of spinal
cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a
prospective randomised controlled study. Eur J Vasc Endovasc Surg. 1995; 9: 421-
5.
Johnson, B.F., Evans, L., Drury, R., Datta, D., Morris-Jones, W. and Beard, J.D. Surgery
for limb threatening ischaemia: a reappraisal of the costs and benefits. Eur J Vasc
Endovasc Surg. 1995; 9: 181-8.
Johnston, S.L., Lock, R.J. and Gompels, M.M. Takayasu arteritis: a review. J Clin Pathol.
2002; 55: 481-6.
Jones, L.E. Lower limb amputation in three Australian states. Int Disabil Stud. 1990; 12:
37-40.
Juergens, J.L., Barker, N.W. and Hines, E.A., Jr. Arteriosclerosis obliterans: review of 520
cases with special reference to pathogenic and prognostic factors. Circulation.
1960; 21: 188-95.
Kannel, W.B. and McGee, D.L. Update on some epidemiologic features of intermittent
claudication: the Framingham Study. J Am Geriatr Soc. 1985; 33: 13-8.
Kantonen, I., Lepantalo, M., Salenius, J.P., Forsstrom, E., Hakkarainen, T., Huusari, H.,
Jaakkola, A., Kaarne, M., Kaartinen, P., Kivivuori, R., Kostiainen, S., Lehtonen, J.,
90
Loponen, P., Luther, M., Maenpaa, I., Nikula, P., Riekkinen, H., Rissanen, K.,
Vilkko, P. and Ylonen, K. Auditing a nationwide vascular registry--the 4-year
Finnvasc experience. Finnvasc Study Group. Eur J Vasc Endovasc Surg. 1997; 14:
468-74.
Karlstrom, L. and Bergqvist, D. Effects of vascular surgery on amputation rates and
mortality. Eur J Vasc Endovasc Surg. 1997; 14: 273-83.
Kavanagh, T.G., Cannon, S.R., Pringle, J., Stoker, D.J. and Kemp, H.B. Paraosteal
osteosarcoma. Treatment by wide resection and prosthetic replacement. J Bone
Joint Surg Br. 1990; 72: 959-65.
Kazmers, A., Perkins, A.J. and Jacobs, L.A. Major lower extremity amputation in Veterans
Affairs medical centers. Ann Vasc Surg. 2000; 14: 216-22.
Kellicut, D.C., 3rd, Sidawy, A.N. and Arora, S. Diabetic vascular disease and its
management. Semin Vasc Surg. 2003; 16: 12-8.
Klomp, H.M., Spincemaille, G.H., Steyerberg, E.W., Habbema, J.D. and van Urk, H.
Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study
Group. Lancet. 1999; 353: 1040-4.
Klomp, H.M. and Steyerberg, E.W. Systematic review and meta-analysis of controlled
trials assessing spinal cord stimulation for inoperable critical leg ischaemia, author
reply. Br J Surg. 2005; 92: 120; author reply 120-1.
Korn, P., Hoenig, S.J., Skillman, J.J. and Kent, K.C. Is lower extremity revascularization
worthwhile in patients with end-stage renal disease? Surgery. 2000; 128: 472-9.
Kroger, K., Suckel, A., Hirche, H. and Rudofsky, G. Different prevalence of asymptomatic
atherosclerotic lesions in males and females. Vasc Med. 1999; 4: 61-5.
Krupski, W.C. Overview of extremity amputations. In: R.B. Rutherford, P. Gloviczki, K.W.
Johnston, R.F. Kempczinski and W.C. Krupski (Eds.), Vascular Surgery, Vol. 2,
Saunders, Denver, 2000, pp. 2175-84.
Kuukasjarvi, P. and Salenius, J.P. Perioperative outcome of acute lower limb ischaemia on
the basis of the national vascular registry. The Finnvasc Study Group. Eur J Vasc
Surg. 1994; 8: 578-83.
Laakso, M., Reunanen, A., Klaukka, T., Aromaa, A., Maatela, J. and Pyorala, K. Changes
in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987.
Am J Epidemiol. 1991; 133: 850-7.
Laaperi, T., Pohjolainen, T., Alaranta, H. and Karkkainen, M. Lower-limb amputations. Ann
Chir Gynaecol. 1993; 82: 183-7.
Larsson, J., Apelqvist, J., Agardh, C.D. and Stenstrom, A. Decreasing incidence of major
amputation in diabetic patients: a consequence of a multidisciplinary foot care team
approach? Diabet Med. 1995; 12: 770-6.
Laxdal, E., Jenssen, G.L., Pedersen, G. and Aune, S. Subintimal angioplasty as a
treatment of femoropopliteal artery occlusions. Eur J Vasc Endovasc Surg. 2003;
25: 578-82.
Le Hello, C., Levesque, H., Jeanton, M., Cailleux, N., Galateau, F., Peillon, C., Veyssier,
P., Watelet, J., Letellier, P., Courtois, H. and Maiza, D. Lower limb giant cell arteritis
and temporal arteritis: followup of 8 cases. J Rheumatol. 2001; 28: 1407-12.
Leather, R.P., Shah, D.M., Chang, B.B. and Kaufman, J.L. Resurrection of the in situ
saphenous vein bypass. 1000 cases later. Ann Surg. 1988; 208: 435-42.
Lepantalo, M., Biancari, F. and Tukiainen, E. Never amputate without consultation of a
vascular surgeon. Diabetes Metab Res Rev. 2000; 16 Suppl 1: S27-32.
91
Lepantalo, M. and Matzke, S. Outcome of unreconstructed chronic critical leg ischaemia.
Eur J Vasc Endovasc Surg. 1996; 11: 153-7.
Lepantalo, M., Vuorisalo, S. and Lassila, R. Unexpected causes of acute lower limb
ischemia. In: J.N. Branchereaua (Ed.), Unexpected challenges in vascular surgery,
Blackwell futura, Oxford, 2005, pp. 185194.
Liedberg, E. and Persson, B.M. Age, diabetes and smoking in lower limb amputation for
arterial occlusive disease. Acta Orthop Scand. 1983; 54: 383-8.
Lindholt, J.S., Bovling, S., Fasting, H. and Henneberg, E.W. Vascular surgery reduces the
frequency of lower limb major amputations. Eur J Vasc Surg. 1994; 8: 31-5.
Lofberg, A.M., Karacagil, S., Ljungman, C., Westman, B., Bostrom, A., Hellberg, A. and
Ostholm, G. Percutaneous transluminal angioplasty of the femoropopliteal arteries
in limbs with chronic critical lower limb ischemia. J Vasc Surg. 2001; 34: 114-21.
Lofberg, A.M., Lorelius, L.E., Karacagil, S., Westman, B., Almgren, B. and Berqgvist, D.
The use of below-knee percutaneous transluminal angioplasty in arterial occlusive
disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol. 1996;
19: 317-22.
LoGerfo, F.W. and Marcaccio, E.J. Etiology and assessment of ischemia in the diabetic.
Ann Chir Gynaecol. 1992; 81: 122-4.
London, N.J., Srinivasan, R., Naylor, A.R., Hartshorne, T., Ratliff, D.A., Bell, P.R. and
Bolia, A. Subintimal angioplasty of femoropopliteal artery occlusions: the long-term
results. Eur J Vasc Surg. 1994; 8: 148-55.
London, N.J., Varty, K., Sayers, R.D., Thompson, M.M., Bell, P.R. and Bolia, A.
Percutaneous transluminal angioplasty for lower-limb critical ischaemia. Br J Surg.
1995; 82: 1232-5.
Lundberg, G., Markers of tissue ischaemia in lower limb arterial insufficiency
- an experimental and clinical study, Department of Surgical Sciences, Karolinska Institute,
Stockholm, 2005.
Luther, M. The influence of arterial reconstructive surgery on the outcome of critical leg
ischaemia. Eur J Vasc Surg. 1994; 8: 682-9.
Luther, M. Treatment of chronic critical leg ischaemia--a cost benefit analysis. Ann Chir
Gynaecol Suppl. 1997; 213: 1-142.
Luther, M. Klaudikation, kritisk iskemi och livskvalitet. Finska Läkaresällskapets
Handlingar. 2002; 162(2): 14-19.
Luther, M. Fate of the patient with chronic limb ischaemia, The 7th Annual Meeting of the
Scandinavian Association for Vascular Surgery, Tampere, Finland, 2003.
Luther, M., Kantonen, I., Lepantalo, M., Salenius, J. and Group, K.Y. Arterial intervention
and reduction in amputation for chronic critical leg ischaemia. Br J Surg. 2000; 87:
454-8.
Luther, M. and Lepantalo, M. Femoropopliteal reconstructions--influence of risk factors on
outcome. Ann Chir Gynaecol. 1996; 85: 238-46.
Luther, M. and Lepantalo, M. Arterial reconstruction to the foot arteries--a viable option?
Eur J Surg. 1997a; 163: 659-65.
Luther, M. and Lepantalo, M. Femorotibial reconstructions for chronic critical leg
ischaemia: influence on outcome by diabetes, gender and age. Eur J Vasc
Endovasc Surg. 1997b; 13: 569-77.
Luther, M., Lepantalo, M., Alback, A. and Matzke, S. Amputation rates as a measure of
vascular surgical results. Br J Surg. 1996; 83: 241-4.
92
Marcoux, R.M., Larrat, E.P., Taubman, A.H. and Wilson, J. Screening for peripheral
arterial disease. J Am Pharm Assoc (Wash). 1996; NS36: 370-3.
Matsagas, M.I., Rivera, M.A., Tran, T., Mitchell, A., Robless, P., Davies, A.H. and
Geroulakos, G. Clinical outcome following infra-inguinal percutaneous transluminal
angioplasty for critical limb ischemia. Cardiovasc Intervent Radiol. 2003; 26: 251-5.
Matsi, P. Percutaneous transluminal angioplasty in critical limb ischaemia. Ann Chir
Gynaecol. 1995; 84: 359-62.
Matsubara, J., Sakamoto, S., Shikata, H., Hida, K., Kobayashi, M., Kobata, T. and Kurose,
K. Is arterial surgery advisable for patients over 80 years of age? J Cardiovasc Surg
(Torino). 2001; 42: 375-9.
Mattes, E., Norman, P.E. and Jamrozik, K. Falling incidence of amputations for peripheral
occlusive arterial disease in Western Australia between 1980 and 1992. Eur J Vasc
Endovasc Surg. 1997; 13: 14-22.
Matzke, S. and Lepantalo, M. Claudication does not always precede critical leg ischemia.
Vasc Med. 2001; 6: 77-80.
McDermott, M.M., Greenland, P., Liu, K., Criqui, M.H., Guralnik, J.M., Celic, L. and Chan,
C. Sex differences in peripheral arterial disease: leg symptoms and physical
functioning. J Am Geriatr Soc. 2003; 51: 222-8.
McLoughlin, R.F., Fitzgerald, L.P. and O'Donnell, J.A. Limb salvage in the elderly. Ann
Vasc Surg. 1989; 3: 11-3.
McWhinnie, D.L., Gordon, A.C., Collin, J., Gray, D.W. and Morrison, J.D. Rehabilitation
outcome 5 years after 100 lower-limb amputations. Br J Surg. 1994; 81: 1596-9.
Meier, R.H. Rehabilitation of the person with an amputation. In: R.B. Rutherford, J.L.
Cronenwett, P. Gloviczki, K.W. Johnston, R.F. Kempczinski and W.C. Krupski
(Eds.), Vascular surgery, Vol. 2, Saunders, Denver, 2000, pp. 2227-48.
Meyerson, S.L., Skelly, C.L., Curi, M.A., Desai, T.R., Katz, D., Bassiouny, H.S., McKinsey,
J.F., Gewertz, B.L. and Schwartz, L.B. Long-term results justify autogenous
infrainguinal bypass grafting in patients with end-stage renal failure. J Vasc Surg.
2001; 34: 27-33.
Mills, J.L., Sr. Buerger's disease in the 21st century: diagnosis, clinical features, and
therapy. Semin Vasc Surg. 2003; 16: 179-89.
Mills, J.L., Taylor, L.M., Jr. and Porter, J.M. Buerger's disease in the modern era. Am J
Surg. 1987; 154: 123-9.
Molloy, K.J., Nasim, A., London, N.J., Naylor, A.R., Bell, P.R., Fishwick, G., Bolia, A. and
Thompson, M.M. Percutaneous transluminal angioplasty in the treatment of critical
limb ischemia. J Endovasc Ther. 2003; 10: 298-303.
Moniz, M.P., Ombrellaro, M.P., Stevens, S.L., Freeman, M.B., Diamond, D.L. and
Goldman, M.H. Concomitant orthopedic and vascular injuries as predictors for limb
loss in blunt lower extremity trauma. Am Surg. 1997; 63: 24-8.
Moran, S.L., Illig, K.A., Green, R.M. and Serletti, J.M. Free-tissue transfer in patients with
peripheral vascular disease: a 10-year experience. Plast Reconstr Surg. 2002; 109:
999-1006.
Morris, A.D., McAlpine, R., Steinke, D., Boyle, D.I., Ebrahim, A.R., Vasudev, N., Stewart,
C.P., Jung, R.T., Leese, G.P., MacDonald, T.M. and Newton, R.W. Diabetes and
lower-limb amputations in the community. A retrospective cohort study.
DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside
Scotland/Medicines Monitoring Unit. Diabetes Care. 1998; 21: 738-43.
93
Murabito, J.M., D'Agostino, R.B., Silbershatz, H. and Wilson, W.F. Intermittent
claudication. A risk profile from The Framingham Heart Study. Circulation. 1997; 96:
44-9.
Mätzke, S., Identification and outcome of critical leg ischaemia, Helsinki University,
Helsinki, 2004.
Nasr, M.K., McCarthy, R.J., Hardman, J., Chalmers, A. and Horrocks, M. The increasing
role of percutaneous transluminal angioplasty in the primary management of critical
limb ischaemia. Eur J Vasc Endovasc Surg. 2002; 23: 398-403.
Nehler, M.R., Moneta, G.L., Edwards, J.M., Yeager, R.A., Taylor, L.M., Jr. and Porter, J.M.
Surgery for chronic lower extremity ischemia in patients eighty or more years of
age: operative results and assessment of postoperative independence. J Vasc
Surg. 1993; 18: 618-24; discussion 624-6.
Norgren, L., Alwmark, A., Angqvist, K.A., Hedberg, B., Bergqvist, D., Takolander, R.,
Claes, G., Lundell, A., Holm, J., Jivegard, L. and et al. A stable prostacyclin
analogue (iloprost) in the treatment of ischaemic ulcers of the lower limb. A
Scandinavian-Polish placebo controlled, randomised multicenter study. Eur J Vasc
Surg. 1990; 4: 463-7.
O'Mara, C.S., Kilgore, T.L., Jr., McMullan, M.H., Maples, M.D., Hollingsworth, J.F. and
Tyler, H.B. Distal bypass for limb salvage in very elderly patients. Am Surg. 1987;
53: 66-70.
Onkamo, P., Vaananen, S., Karvonen, M. and Tuomilehto, J. Worldwide increase in
incidence of Type I diabetes--the analysis of the data on published incidence
trends. Diabetologia. 1999; 42: 1395-403.
Ostrup, L.T. and Vilkki, S.K. Reconstructive microsurgery--a review. Acta Orthop Scand.
1986; 57: 395-401.
Ouriel, K. Thrombolysis or operation for peripheral arterial occlusion. Vasc Med. 1996; 1:
159-61.
Ouriel, K., Fiore, W.M. and Geary, J.E. Limb-threatening ischemia in the medically
compromised patient: amputation or revascularization? Surgery. 1988; 104: 667-72.
Ouriel, K., Shortell, C.K., DeWeese, J.A., Green, R.M., Francis, C.W., Azodo, M.V.,
Gutierrez, O.H., Manzione, J.V., Cox, C. and Marder, V.J. A comparison of
thrombolytic therapy with operative revascularization in the initial treatment of acute
peripheral arterial ischemia. J Vasc Surg. 1994; 19: 1021-30.
Parsons, R.E., Suggs, W.D., Lee, J.J., Sanchez, L.A., Lyon, R.T. and Veith, F.J.
Percutaneous transluminal angioplasty for the treatment of limb threatening
ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg.
1998; 28: 1066-71.
Pell, J.P., Donnan, P.T., Fowkes, F.G. and Ruckley, C.V. Quality of life following lower
limb amputation for peripheral arterial disease. Eur J Vasc Surg. 1993; 7: 448-51.
Pell, J.P., Fowkes, F.G., Ruckley, C.V., Clarke, J., Kendrick, S. and Boyd, J.H. Declining
incidence of amputation for arterial disease in Scotland. Eur J Vasc Surg. 1994; 8:
602-6.
Pell, J.P. and Fowkes, F.G.R. Risk factors for critical limb ischaemia. Epidemiol Update.
1997; 2: 19-25.
Peltonen, S., Biancari, F., Lindgren, L., Makisalo, H., Honkanen, E. and Lepantalo, M.
Outcome of infrainguinal bypass surgery for critical leg ischaemia in patients with
chronic renal failure. Eur J Vasc Endovasc Surg. 1998; 15: 122-7.
94
Pezzin, L.E., Dillingham, T.R. and MacKenzie, E.J. Rehabilitation and the long-term
outcomes of persons with trauma-related amputations. Arch Phys Med Rehabil.
2000; 81: 292-300.
Pohjolainen, T., The Finnish lower-limb amputee, Helsinki University, Helsinki, 1991.
Pohjolainen, T. and Alaranta, H. Lower limb amputations in southern Finland 1984-1985.
Prosthet Orthot Int. 1988; 12: 9-18.
Pohjolainen, T. and Alaranta, H. Epidemiology of lower limb amputees in Southern Finland
in 1995 and trends since 1984. Prosthet Orthot Int. 1999; 23: 88-92.
Pohjolainen, T., Alaranta, H. and Karkkainen, M. Prosthetic use and functional and social
outcome following major lower limb amputation. Prosthet Orthot Int. 1990; 14: 75-9.
Pomposelli, F.B., Jr., Arora, S., Gibbons, G.W., Frykberg, R., Smakowski, P., Campbell,
D.R., Freeman, D.V. and LoGerfo, F.W. Lower extremity arterial reconstruction in
the very elderly: successful outcome preserves not only the limb but also residential
status and ambulatory function. J Vasc Surg. 1998; 28: 215-25.
Pomposelli, F.B., Jr., Jepsen, S.J., Gibbons, G.W., Campbell, D.R., Freeman, D.V., Miller,
A. and LoGerfo, F.W. Efficacy of the dorsal pedal bypass for limb salvage in
diabetic patients: short-term observations. J Vasc Surg. 1990; 11: 745-51;
discussion 751-2.
Pomposelli, F.B., Jr., Marcaccio, E.J., Gibbons, G.W., Campbell, D.R., Freeman, D.V.,
Burgess, A.M., Miller, A. and LoGerfo, F.W. Dorsalis pedis arterial bypass: durable
limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg. 1995;
21: 375-84.
Reekers, J.A. Percutaneous intentional extraluminal (subintimal) revascularization (PIER)
for critical lower limb ischemia: too good to be true? J Endovasc Ther. 2002; 9: 419-
21.
Reekers, J.A. and Bolia, A. Percutaneous intentional extraluminal (subintimal)
recanalization: how to do it yourself. Eur J Radiol. 1998; 28: 192-8.
Reifsnyder, T., Grossman, J.P. and Leers, S.A. Limb loss after lower extremity bypass. Am
J Surg. 1997; 174: 149-51.
Reunanen, A., Takkunen, H. and Aromaa, A. Prevalence of intermittent claudication and
its effect on mortality. Acta Med Scand. 1982; 211: 249-56.
Rommers, G.M., Vos, L.D., Groothoff, J.W., Schuiling, C.H. and Eisma, W.H.
Epidemiology of lower limb amputees in the north of The Netherlands: aetiology,
discharge destination and prosthetic use. Prosthet Orthot Int. 1997; 21: 92-9.
Rutherford, R.B., Baker, J.D., Ernst, C., Johnston, K.W., Porter, J.M., Ahn, S. and Jones,
D.N. Recommended standards for reports dealing with lower extremity ischemia:
revised version. J Vasc Surg. 1997; 26: 517-38.
Salas, C. and Bolia, A. Angioplasty is the first-line treatment in critical limb ischaemia, for
the motion, Charing Cross, London, UK, 2003.
Salenius, J.P., Lepantalo, M., Ylonen, K. and Luther, M. Treatment of peripheral vascular
diseases--basic data from the nationwide vascular registry FINNVASC. Ann Chir
Gynaecol. 1993; 82: 235-40.
Sayers, R.D., Raptis, S., Berce, M. and Miller, J.H. Long-term results of femorotibial
bypass with vein or polytetrafluoroethylene. Br J Surg. 1998; 85: 934-8.
Sayers, R.D., Thompson, M.M., Hartshorne, T., Budd, J.S. and Bell, P.R. Treatment and
outcome of severe lower-limb ischaemia. Br J Surg. 1994; 81: 521-3.
95
Sayers, R.D., Thompson, M.M., London, N.J., Varty, K., Naylor, A.R., Budd, J.S., Ratliff,
D.A. and Bell, P.R. Selection of patients with critical limb ischaemia for femorodistal
vein bypass. Eur J Vasc Surg. 1993; 7: 291-7.
Scher, L.A., Veith, F.J., Ascer, E., White, R.A., Samson, R.H., Sprayregen, S. and Gupta,
S.K. Limb salvage in octogenarians and nonagenarians. Surgery. 1986; 99: 160-5.
Second European Consensus Document. Second European Consensus Document on
chronic critical leg ischemia. Eur J Vasc Surg. 1992; 6 Suppl A: 1-32.
Shearman, C.P., Beard, J.D. and Gaines, P.A. Treatment of chronic lower limb ischaemia.
In: J.D. Beard and P.A. Gaines (Eds.), Saunders, London, 2000, pp. 47-81.
Shigematsu, H. and Shigematsu, K. Factors affecting the long-term outcome of Buerger's
disease (thromboangiitis obliterans). Int Angiol. 1999; 18: 58-64.
Smith, I., Franks, P.J., Greenhalgh, R.M., Poulter, N.R. and Powell, J.T. The influence of
smoking cessation and hypertriglyceridaemia on the progression of peripheral 
arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg.
1996; 11: 402-8.
Solonen, K.A. and Huittinen, V.M. Amputaatiot ja proteesit, Proteesisäätiö, Helsinki, 1991.
Spinosa, D.J., Leung, D.A., Matsumoto, A.H., Bissonette, E.A., Cage, D., Harthun, N.L.,
Kern, J.A., Angle, J.F., Hagspiel, K.D., Crosby, I.K., Wellons, H.A., Jr., Tribble, C.G.
and Hartwell, G.D. Percutaneous intentional extraluminal recanalization in patients
with chronic critical limb ischemia. Radiology. 2004; 232: 499-507.
Steck, A. and Rewers, M. Epidemiology and geography of type I diabetes mellitus. In: R.A.
DeFronzo, E. Ferranini, H. Keen and P. Zimmet (Eds.), Textbook of diabetes
mellitus, Chichester, West Sussex, 2004.
Sweetnam, R. Osteosarcoma. Ann R Coll Surg Engl. 1969; 44: 38-58.
Sweetnam, R. The diminishing role of amputation in the management of malignant
tumours of bone. Ann R Coll Surg Engl. 1991; 73: 165-9.
Sweetnam, R., Knowelden, J. and Seddon, H. Bone sarcoma: treatment by irradiation,
amputation, or a combination of the two. Br Med J. 1971; 2: 363-7.
TASC. Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society
Consensus (TASC). Eur J Vasc Endovasc Surg. 2000; 19 Suppl A: Si-xxviii, S1-
250.
Taylor, L.M., Jr., Hamre, D., Dalman, R.L. and Porter, J.M. Limb salvage vs amputation for
critical ischemia. The role of vascular surgery. Arch Surg. 1991; 126: 1251-7;
discussion 1257-8.
The Oral Iloprost in severe Leg Ischaemia Study Group. Two randomised and placebo-
controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg
ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group. Eur J Vasc
Endovasc Surg. 2000; 20: 358-62.
The U.K. Severe Limb Ischaemia Study Group. Treatment of limb threatening ischaemia
with intravenous iloprost: a randomised double-blind placebo controlled study. U.K.
Severe Limb Ischaemia Study Group. Eur J Vasc Surg. 1991; 5: 511-6.
The Vascular Surgical Society of Great Britain and Ireland. Critical limb ischaemia:
management and outcome. Report of a national survey. The Vascular Surgical
Society of Great Britain and Ireland. Eur J Vasc Endovasc Surg. 1995; 10: 108-13.
Tisi, P.V., Mirnezami, A., Baker, S., Tawn, J., Parvin, S.D. and Darke, S.G. Role of
subintimal angioplasty in the treatment of chronic lower limb ischaemia. Eur J Vasc
Endovasc Surg. 2002; 24: 417-22.
Tukiainen, E., Biancari, F. and Lepantalo, M. Lower limb revascularization and free flap
transfer for major ischemic tissue loss. World J Surg. 2000; 24: 1531-6.
96
Tunis, S.R., Bass, E.B. and Steinberg, E.P. The use of angioplasty, bypass surgery, and
amputation in the management of peripheral vascular disease. N Engl J Med. 1991;
325: 556-62.
Turney, B.W., Kent, S.J., Walker, R.T. and Loftus, I.M. Amputations: no longer the end of
the road. J R Coll Surg Edinb. 2001; 46: 271-3.
Wahlberg, E., Lepner, U. and Olofsson, P. Limb loss in association with vascular surgery--
a five-year series of major lower-limb amputation. Eur J Surg. 1994; 160: 561-7.
Van Damme, H., De Leval, L., Creemers, E. and Limet, R. Thrombangiitis obliterans
(Buerger's disease): still a limb threatening disease. Acta Chir Belg. 1997; 97: 229-
36.
van Houtum, W.H., Rauwerda, J.A., Ruwaard, D., Schaper, N.C. and Bakker, K. Reduction
in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000.
Diabetes Care. 2004; 27: 1042-6.
Vanoli, M., Bacchiani, G., Origg, L. and Scorza, R. Takayasu's arteritis: a changing
disease. J Nephrol. 2001; 14: 497-505.
Varty, K., Nydahl, S., Nasim, A., Bolia, A., Bell, P.R. and London, J.M. Results of surgery
and angioplasty for the treatment of chronic severe lower limb ischaemia. Eur J
Vasc Endovasc Surg. 1998; 16: 159-63.
Vermassen, F.E. and van Landuyt, K. Combined vascular reconstruction and free flap
transfer in diabetic arterial disease. Diabetes Metab Res Rev. 2000; 16 Suppl 1:
S33-6.
Vig, S., Chitolie, A., Sleight, S., Bevan, D., Dormandy, J., Thompson, M.M. and Halliday,
A. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc
Endovasc Surg. 2004; 28: 124-31.
Wilson, S.E., Wolf, G.L. and Cross, A.P. Percutaneous transluminal angioplasty versus
operation for peripheral arteriosclerosis. Report of a prospective randomized trial in
a selected group of patients. J Vasc Surg. 1989; 9: 1-9.
Winell, K. The National Hospital Registry data on lower limb amputations quality indicator
for diabetes care?, XIX Annual Meeting  of  the European Society for Vascular
Surgery, Helsinki, Finland, 2005.
Virkkunen, J., Heikkinen, M., Lepantalo, M., Metsanoja, R. and Salenius, J.P. Diabetes as
an independent risk factor for early postoperative complications in critical limb
ischemia. J Vasc Surg. 2004; 40: 761-7.
Witso, E. and Ronningen, H. Lower limb amputations: registration of all lower limb
amputations performed at the University Hospital of Trondheim, Norway, 1994-
1997. Prosthet Orthot Int. 2001; 25: 181-5.
Wolfe, J.H. and Wyatt, M.G. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg.
1997; 13: 578-82.
Wolfe, J.N. Defining the outcome of critical ischaemia: a one year prospective study. Br J
Surg. 1986; 73: 321.
Wolfle, K.D., Bruijnen, H., Loeprecht, H., Rumenapf, G., Schweiger, H., Grabitz, K.,
Sandmann, W., Lauterjung, L., Largiader, J., Erasmi, H., Kasprzak, P.M., Raithel,
D., Allenberg, J.R., Lauber, A., Berlakovich, G.M., Kretschmer, G., Hepp, W.,
Becker, H.M. and Schulz, A. Graft patency and clinical outcome of femorodistal
arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre
comparative analysis. Eur J Vasc Endovasc Surg. 2003; 25: 229-34.
97
Yeager, R.A., Moneta, G.L., Taylor, L.M., Jr., Hamre, D.W., McConnell, D.B. and Porter,
J.M. Surgical management of severe acute lower extremity ischemia. J Vasc Surg.
1992; 15: 385-91; discussion 392-3.
Yilmaz, S., Sindel, T., Yegin, A. and Luleci, E. Subintimal angioplasty of long superficial
femoral artery occlusions. J Vasc Interv Radiol. 2003; 14: 997-1010.
Zarins, C.K., Lu, C.T., McDonnell, A.E. and Whitehouse, W.M., Jr. Limb salvage by
percutaneous transluminal recanalization of the occluded superficial femoral artery.
Surgery. 1980; 87: 701-8.
Zdanowski, Z., Troeng, T. and Norgren, L. Outcome and influence of age after
infrainguinal revascularisation in critical limb ischaemia. The Swedish Vascular
Registry. Eur J Vasc Endovasc Surg. 1998; 16: 137-41.
14. ORIGINAL PUBLICATIONS
